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Abstract
The human erythrocyte glucose transport protein (GLUTl)
interacts with, and is regulated by, cytosolic ATP. This study asks
the following questions concerning ATP modulation of GLUTI
mediated sugar transport. 1) Which region(s) of GLUTI form the
adenine nucleotide-binding domain? 2) What factors influence A 
modulation of sugar transport? 3) Is A TP interaction with GLUTI
sufficient for sugar transport regulation?
The first question was addressed through peptide mappmg,
terminal sequencmg, and alanine scannmg mutagenesis of GLUTI
usmg (3 2P) -azidoA TP, a photoacti vatable A TP analog. We then used a
combination of transport measurements and photolabeling
strategies to examine how glycolytic intermediates, pH, and
transporter oligomeric structure affect A TP regulation of sugar
transport. Finally, GLUTI was reconstituted into proteoliposomes 
determine whether A TP is sufficient for the modulation of GLUTI
function in-vitro.
Vll
This thesis presents data supporting the hypothesis that residues
332-335 contribute to the efficiency of adenine nucleotide binding
to GLUTl. In addition , we show that AMP, acidification, and
conversion of the transporter to its dimeric form antagonize A 
regulation of sugar transport. Finally, we present results that
support the proposal that A TP interaction with GLUTI is sufficient
for transport modulation.
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Introduction
selectively permeable barrier, the cell membrane, surrounds
all mammalian cells. This barrier is composed primarily of lipids
and proteins. The hydrophobic nature of this cell membrane allows
non-polar molecules, and only the very smallest polar molecules 
pass through by simple diffusion. In contrast, polar molecules larger
than water such as ions, sugars, ammo acids, nucleotides , and cell
metabolites must be transported across the cell membrane by
specialized integral membrane proteins which function as channels
or carriers. The channels are water filled pores that allow substances
(selected on the basis of charge and size) to diffuse down an
electrochemical gradient across membranes.
In contrast, carrier proteins transfer bound solutes across
membranes by way of conformational changes. Two types of
mediated transport have been described , facilitated and active.
Facilitated transport is characterized by rapid, protein mediated
bidirectional transport of solutes across the membrane, down 
electrochemical gradient. Active transport couples a metabolic
energy source (i.e. A TP) to the rapid protein mediated movement of
solute against a concentration gradient (Carruthers, 1990).
Glucose, a hexose monosaccharide, is an essential source 
energy m mammalian and non-mammalian cells. Cellular metabolic
machinery reqUIres D-glucose for the production of A TP (Darnell
1990). A family of facilitative glucose transporters selectively pump
glucose across cell membranes with a net movement of sugar from
areas of high concentration to areas of low concentration (Stein,
1986). Stereoselectivity, saturation kinetics, and inhibition by the
fungal metabolite cytochalasin B (CCB) characterize these facilitative
glucose transporters.
Five mammalian glucose transporter isoforms have been
identified in the facilitative glucose transporter family. These five
isoforms are highly homologous (50-80%) yet exhibit distinct tissue
distributions (Gould and Bell , 1990). GLUTl , the erythrocyte glucose
transporter, is found in virtually all mammalian tissues including
red blood cells , brain microvessels , kidney, colon, and placenta
(Mueckler et aI., 1985; Birnbaum et aI. , 1986; Gould and Bell , 1990).
GLUT2, the liver type transporter, is located in liver, kidney, small
intestine, and pancreatic -cells (Thorens et aI. , 1988). The presence
of GLUT3 in fibroblasts and blood vessels suggests a ubiquitous
tissue distribution (Kayano et aI., 1988). GLUT4, the insulin
sensitive transporter, is found in skeletal and cardiac muscle as well
as adipocytes (Birnbaum, 1989; Charron et aI., 1989; Fukumoto et
aI., 1989; James et aI. , 1989; Kaestner et aI. , 1989). GLUT5, a
fructose transporter, is found primarily in the small intestine with
lower levels of expression identified in kidney, skeletal muscle, and
subcutaneous fat (Kayano et aI. , 1990).
The goal of this laboratory is to understand all aspects of
faciltative glucose transport. To accomplish this, we have chosen to
study GLUT1 , the human erythrocyte form of the facilitative glucose
transporter. Specifically, our interest lies in understanding how
GLUTI-mediated sugar transport is regulated. Certain characteristics
of GLUTI make it ideal for studying transport regulation. First
GLUTI comprises 6% of total human red blood cell protein. The ease
with which these erythrocytes can be acquired facilitates the
purification of large quantities (10-20 mg/unit of blood) of the
transporter for use in experimental protocols. In addition, the
cytosolic environment of red blood cells can be readily controlled
by reversible hypotonic lysis, thereby permitting analysis of
cytosolic determinants of transport.
Sugar Transport Regulation
Certain cell types , such as skeletal and cardiac muscle
adipocytes, and nucleated avian erythrocytes can metabolize sugar
at rates that exceed transport capacity. Under these conditions
glucose transport becomes the rate- limiting step in sugar utilization
and cells become susceptible 
.to acute transport regulation (Elbrink
and Bihler, 1975; Carruthers, 1990).
Compounds that regulate glucose carner function can be divided
into two groups: hormones and metabolic factors. The primary
hormone to which GLUTs respond is insulin, which is secreted by
the pancreatic islets in response to changing blood nutrient levels
(Vander 1990). Cells that respond to insulin include adipocytes and
muscle. In contrast, metabolic factors such as anOXIa, ischemia
exercise, and metabolic pOIsons, have been shown to affect skeletal
muscle, cardiac muscle, and nucleated aVIan erythrocytes. In either
case, exposure to these substances and conditions stimulates glucose
uptake (Carruthers, 1990).
Two hypotheses exist which explain the mechanisms governIng
transport acceleration. Transport capacity is defined by the
following equation: V max = Kcat (E)t where Kcat represents the
catalytic turnover of an enzyme , and (E)t is equal to total enzyme
concentration. It is apparent from this relationship that an increase
in either transporter catalytic turnover or transporter number
would alter transport capacity (V max)' The recruitment hypothesis
suggests that transport stimulation is a direct result of transporter
redistribution to the ' plasma membrane from a subcellular pool
(increased (E)t) (Cushman and Wardzala, 1980; Suzuki and Kono,
1980). In contrast, the activation hypothesis implies' that transport
acceleration is the result of an increase in the intrinsic activity of
transporters already present in the membrane (increased kcat
(Carruthers, 1990). Individually, carner recruitment or activation
could result in sugar transport stimulation. However, these two
mechanisms could also function coordinately in cells. Under these
conditions, inactivation and reinternalization would result in
transport inhibition (Carruthers, 1990).
The following sections present four model cell types that exhibit
acute regulation of glucose transport , skeletal and cardiac muscle
avian erythrocytes, and human red blood cells.
Skeletal Muscle
Skeletal muscle is the primary site of glucose disposal in-vivo
(Douen et aI., 1990; Klip and Paquet, 1990). Sugar transport in this
tissue is maximally stimulated by insulin, as well as exercise,
anoxia/hypoxia, ischemia, and inhibition of oxidative
phosphorylation, all of which result in an increased demand for A 
(Clausen, 1975; Elbrink and Bihler, 1975). Subcellular fractionation
and cytochalasin B binding experiments have shown that
stimulation is characterized by a two-fold increase in plasma
membrane and t- tubule carrier levels (Hirshman et aI., 1988;
Wheeler, 1988; Douen et aI. , 1990; Cartee et aI., 1991; Goodyear 
aI. , 1991).
Experimentally, striated muscle has been found to contain two
transporter isoforms: GLUT 1 (Mueckler et aI., 1985; Birnbaum et aI.,
1986; Gould and Bell, 1990) and GLUT4 (Cushman and Wardzala,
1980; Birnbaum, 1989; Charron et aI. , 1989; James et aI., 1989).
GLUT1 , detected primarily at the cell surface, is proposed to be
responsible for basal transport rates in unstimulated skeletal muscle
(James et aI. , 1988). In contrast, transport stimulation due to anOXIa
and exercise appears to result from GLUT4 translocation to the cell
membrane from an intracellular compartment (Douen et aI. , 1990;
Gao et aI. , 1994). More recent evidence has suggested that skeletal
rilUscle contains a pool of conformationally masked GLUT4 that
becomes exposed during transport stimulation (Wang et aI. , 1996).
Supplementary experiments have indicated that GLUT4
translocation in skeletal muscle is not sufficient to account for the
level of transport stimulation observed in response to anoxia and
exercise (Morgan et aI. , 1959; Morgan et aI. , 1961; Morgan et aI.
1965; Sternlicht et aI., 1988; Wheeler, 1988; Klip and Paquet, 1990).
The implication is that transport stimulation in skeletal muscle may
be due to both an Increase in the turnover rate of existing carners
as well as the total number of transporters present (Sternlicht et aI.
- 1988; Klip and Paquet, 1990).
The degree to which recruitment and activation contribute to
exercise, anoxia, and metabolic-depletion induced transport
stimulation in skeletal muscle has not yet been determined.
Carruthers suggests that this question might be answered by
measunng transport kinetics and carrier capacity in sarcoplasmic
vesicles isolated from basal and stimulated muscle (Carruthers
1990). The structural complexity of skeletal muscle and the lack of
definitive markers for subcellular fractions make this a technically
difficult task that has hindered analysis (Klip and Paquet, 1990)
;Cardiac Muscle
Ii \ Two major glucose transporter isoforms - GLUTI and GLUT4 -
'are expressed in cardiac muscle. Levels of GLUT 1 (Calderhead et aI.
"1990; Kraegen et aI. , 1993) were found to be 3 to 4 fold greater in
;h.eart muscle than in skeletal muscle (Doria et aI. , 1993). In the
bsence of insulin GLUT4 is localized to tubulovesicular elements
tadjacent to the sarcolemma and transverse tubules (Fischer et aI.,
1997). Immunohistochemical techniques have detected GLUTI 
cardiomyocyte plasma membranes and intercalated discs (Doria et
aI., 1993). Subcellular fractionation has revealed that a significant
quantity of GLUTI is also present in intracellular membranes
(Fischer et aI. , 1995; Fischer et aI. , 1997). Both carners were found
to undergo translocation from an intracellular compartment to the
cell surface in response to ischemia, hypoxia or contractile activity
(Kolter et aI., 1992; Doria et aI. , 1993; Sun et aI. , 1994; Wheeler 
aI., 1994; Zorzano et aI., 1997). This is contrary to what is proposed
to occur in skeletal muscle, where GLUTI is detected only at the
plasma membrane (James et aI. , 1988). Fischer et al (1997)
identified two intracellular pools of carrier in cardiomyocytes that
are available for translocation, one of which contained significant
quantities of GLUTl. The evidence suggests that this pool of carriers
is insulin insensitive (Fischer et aI. , 1997). It is not yet certain
whether transport stimulation in heart muscle results from
transporter recruitment alone, or occurs in combination with cell
surface transporter activation. Wheeler found that glucose
transporters in the heart show a 50% increase in membrane levels in
response to anOXIa compared to a 150% increase in glucose uptake
(Wheeler, 1988). In contrast, studies undertaken by Haworth et al
showed that anOXIa Increases glucose transport in rat
cardiomyocytes 10-20 fold (Haworth and Berkoff 1986). In heart, as
in skeletal muscle, it appears that translocation may not account for
the degree of transport stimulation seen in response to anoxia
ischemia, and exerCIse. This provides additional evidence that
carrier activation may constitute a necessary part of the process of
transport stimulation.
vianlNucleated Erythrocytes
In contrast to human erythrocytes, aVIan erythrocytes contain
cytosolic structures, primarily mitochondria and a nucleus (Harris
and Brown, 1971; Brown, 1975). Sugar transport in avian
erythrocytes is subject to regulation by cellular metabolic status.
Under basal conditions , protein-mediated net sugar uptake is barely
detectable. Exposure to anoxia or to ' inhibitors of oxidative
metabolism results in a robust stimulation of net sugar uptake
(Cheung et aI., 1977; Simons, 1983). Recent studies have
demonstrated that avian erythrocyte GLUT1 , which is present at the
cell surface at all times (Diamond and Carruthers, 1993), functions
as an antiporter under normoxic conditions (Cloherty et aI. , 1996).
This means that sugar uptake is coupled to sugar exit. Following
metabolic disruption, avian red cell GLUTI can catalyze sugar
uniport (Cloherty et aI. , 1996) allowing net sugar uptake in the
absence of intracellular sugar. Antiport function appears unaffected
by cellular metabolic status. The mediator of this antiport/uniport
switching mechanism is currently unknown. Cloherty et al has
proposed that regulatory factors exist in the avian erythrocyte
which allosterically inhibit GLUTI uniport. Cloherty further
proposes that AMP dependent protein kinase is involved in this
activation/deactivation pathway (Cloherty et aI. , 1996).
While avian erythrocyte GLUTI-mediated sugar uniport is
controlled more completely by cellular metabolic status than is
sugar uniport, the similarity between transport
tissues is striking. Human erythrocyte sugar
mediated by GLUTI (Mueckler et aI. , 1985; Wheeler
and Hinkle
, 1985) which is assembled and functions as an allosteric
homotetramer (Hebert and Carruthers, 1992; Zottola et aI. , 1995). In
. freshly isolated erythrocytes, net uptake of 3-0-methylglucose (a
transported but nonmetabolized sugar) is slower by as much as 150-
fold than 30MG exchange transport (Cloherty et aI. , 1996).
Following hypotonic cell lysis and cellular resealing in A TP-free
medium, 30MG net uptake (but not exchange transport) is
:stimulated by 3 to 10-fold (Helgerson et aI. , 1989). When lysed
erythrocytes are resealed in A TP-containing saline 30MG net
,uptake and exchange are indistinguishable from transport observed
Jin intact cells (Helgerson et aI., 1989). This suggests that as with
vian red cell sugar transport, uptake stimulation in human
, '
erythrocytes results from accelerated uniport function and that
(cytoplasmic A TP may regulate cellular glucose antiport/uniport
(Levine et aI. , 1998).
ATP Regulation of GLUTl in Human Erythrocytes
Human erythrocyte GLUTI is subject to allosteric inhibition by
ATP (Carruthers and Helgerson, 1989; Helgerson et aI., 1989) which
affinity high capacity net sugar uptake to high affinity
uptake. Maximum rates of exchange transport and net
sugar exit appear unaffected by cellular A TP levels (Helgerson et aI.
-- 1989). The net effect of A TP on 30MG uptake at subsaturating sugar
levels (50 to 100 JLM) is to stimulate transport by a factor
to the increase in the ratio V maxi Km(app) while transport
levels greater than Km(app) (saturated transport) is inhibited.
We have demonstrated that the isolated human erythrocyte
.glucose transport protein is also nucleotide binding protein
(Carruthers and Helgerson, 1989). A TP binding to GLUTI promotes
a GLUTI conformational change that leaves the GLUTI carboxyl-
terminus less accessible to peptide-directed antibodies. This A TP-
dependent conformational change is antagonized by AMP and ADP
Which appear to function as competitive inhibitors of A TP binding
to GLUTl. Initial peptide mapping studies identified a range of
,residues from 270-380 as a likely region where A TP attaches
(Carruthers and Helgerson, 1989). The primary sequence of GLUTI
indicates the presence of three potential consensus A TP binding
(Figure 1). Sequence I is a Walker A motif located
i!!
(Ii
" j
etween residues 111- 118, sequence II is a hydrophobic loop motif
hich spans residues 225-229, and sequence III, located at residues
Figure 1. GLUT1 putative topography and consensus ATP binding
domains. The three proposed consensus ATP binding sequences located in
GLUT1 are highlighted in black. Sequence I is a Walker A motif located between
G111 and S117. Sequence II is referred to as a loop motif and stretches from
. K225-K229. Sequence III , a Walker B motif, extends from G332-G343.
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332-343, is a Walker B motif which overlaps with the proposed
region of ATP binding on GLUTI (Walker, 1982 #4492). It is unclear
whether A TP binding to GLUTI is sufficient to mediate sugar
transport regulation in human red blood cells or whether other
molecular species are required.
Wheeler has demonstrated that A TP does not modulate the
activity of reconstituted human GLUTI protein (Wheeler, 1989). 
number of explanations could account for these results. 1) Required
cellular components could be mISSIng or dysfunctional in these
reconstituted vesicles or 2) the GLUTI used in these experiments
may exhibit an abnormal A TP response or capacity to transport
sugar (Carruthers and Helgerson 1989). It is more probable
however, that the problem lies with Wheeler s use of reduced (DTT-
(Hebert and Carruthers, 1992). Work in our laboratory has shown
treated) GLUTI which we have shown to exist as a GLUTI dimer
that conversion of tetrameric GLUT 1 to its dimeric form ablates A 
ii,
binding and A TP modulation of transport (Levine et aI., 1998).
These results imply that A TP modulation of GLUT 1 is dependent
upon transporter quaternary structure. In contrast to Wheeler
, i
work, our studies employ the physiologic, non-reduced form of
GLUTI ( a GLUTI tetra mer (Hebert and Carruthers, 1992)) that
responds to A TP.
In the present study we ask: 1) What physiologic factors
influence A TP-modulation of sugar transport? 2) Is A TP interaction
with GLUTI sufficient for sugar transport regulation? 3) Where is
we use a combination of transport measurements and azidoA 
the GLUT 1 nucleotide-binding domain? To address these questions,
photolabeling strategies to examIne the effects of glycolytic
intermediates, pH changes, and transporter oligomeric structure on
A TP modulation of GLUTl. In addition, reconstitution assays using
purified erythrocyte GLUTI are carried out to determine if A TP 
sufficient for modulation of GLUTI mediated sugar transport.
Finally, peptide mapping, n- terminal sequencing, and alanine
scanning mutagenesis are used to locate the GLUTI A TP binding
Our findings suggest that intracellular AMP and acidification
II:
If!
I:i
A TP regulation of sugar transport, and that A TP-
interaction with GLUTI is sufficient for transport modulation. The
data also support the hypothesis that tetrameric, not dimeric
GLUTl , is regulated by ATP. In addition we show that residues 301-
364 form an integral part of the A TP binding domain on GLUT 
and that epitope tagged human GLUTI expressed in Cos- cells is
normal with respect to sugar transport and azidoA TP binding.
Finally, alanine substitution at residues 338-340 ablates sugar
transport, while alanine substitution at residues 225-229, and 332-
334 increases (32 P)A TP binding.
II!
II'
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Materials and Methods
. Materials. Azido 
(y-
P)ATP was purchased from ICN, Costa Mesa,
CA. (3H)- Methylglucose was purchased from Dupont NEN,
Wilmington, DE. Rabbit antisera (C-Ab) raised against a synthetic
carboxyl-terminal peptide of the rat brain glucose transport protein
(residues 480-492) was obtained from East Acres Biologicals
Southbridge MA. Glycoprotein Detection Kits and ECL detection
reagents were purchased from Amersham Pharmacia Biotech
, ,
Piscataway, NJ. Gradient SDS PAGE gels were purchased from Owl
Scientific, Portsmouth , NH. Nitrocellulose and Immobilon-P were
obtained from Fisher Scientific, Pittsburg, PA. Dulbecco s Modified
Medium FBS, Penicilin/Streptomycin , and G418 (Geneticin)
Were purchased from Gibco BRL Grand Island , NY. The
QuickChange Site-Directed Mutagenesis Kit was acquired from
Stratagene , Marco Island, FL. pcDNA3. 1 + vector was supplied by
Invitrogen
, Carlsbad, CA.
ntibody (mouse monoclonal HA-ab), Endoproteinase Lys-C, and N-
Fugene 6 Transfection Reagent, anti-
- dodecyl-~-D-maltoside were obtained from Roche, Indianapolis , IN.
Nickel-NTA (Ni-NTA) was purchased from Qiagen, Valencia, CA.
Centricon concentrators were acquired from Millipore, Bedford, MA.
materials were purchased from Sigma unless stated
otherwise.
Solutions. Tris medium consisted of 50 mM Tris-HCI , 5 mM MgCl
pH 7.4. Sample buffer (2X) contained 0. 125M Tris-HCI pH 6. 8, 4%
SDS , 20% glycerol, and 50 mM DTT. KCI medium consisted of 150
mM KCI , 10 mM Tris-HCI , 5 mM MgCl , 4 mM EGTA, pH 7.4. Stopper
consisted of ice cold KCI medium plus 10 JlM cytochalasin B , 100 JlM
phloretin , and 10 JlM HgCI , pH 7.4. Lysis buffer contained 10 
Tris HCI, 1 mM EGTA , pH 7.2. Phosphate buffered saline (PBS) :n!
I .u 
contained 171 mM NaCI, 10 mM Na HP0 , 3.4 mM KCI, 1.84 
, pH 7.3. Buffer A included 300 mM NaCI, 10 mM imidazole
20% Glycerol , and 50 mM NaH . Buffer B was composed of Buffer
A + 0. 1 % N-dodecyl ~- maltoside. Buffer C contained 10 mM Tris-
HCI (pH) 7. , 300 mM NaCI , 25 mM imidazole, and 0. 1 % N-dodecyl
maltoside.. Elution buffer consisted of 10 mM Tris-HCI (pH 7.5),
500 mM NaCI, 300 mM imidazole, and 0. 1 % N-dodecyl ~-
maltoside. Krebs Ringer Phosphate (KRP) contained 4.5% NaClt- 
. -
75% KCI, 7.85% CaCI , 19. 1 % MgS0 , and 0. 1 M Na HP0
- --
7,'r:"
' .
Antisera. A peptide corresponding to GLUT 1 residues
88-95 was synthesized by the University of Massachusetts Medical
Kchool Peptide Synthesis facility. This peptide was conjugated to
keyhole limpet hemocyanin USIng a kit purchased from Pierce.
Rabbit antisera (N-Ab) against this GLUTI peptide were obtained
from Animal Pharm Services Inc of Healdsburg, CA. Whole IgGs were
purified from crude serum by ammonium sulfate precipitation
(Sogin and Hinkle, 1980).
- ,
Red Cells. Erythrocytes were isolated from whole human blood by
repeated wash/centrifugation cycles in ice-cold KCI medium. One
volume of whole blood was mixed with 3 volumes of KCI medium
and centrifuged at 10 000 x g for 5 minutes at 4 oC. Serum and the
. Suffy coat were aspirated, and the wash/centrifugation cycle was
until the supernatant was clear and the buffy coat was no
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longer visible. Cells were resuspended in 20 volumes of KCI medium
and, if used in subsequent sugar transport assays, were incubated at
room temperature for 30 minutes in order to deplete intracellular
sugar levels.
Erythrocyte Membrane Ghosts. Washed red cells were lysed in
40 volumes lysis medium, incubated on ice for 10 minutes, then
centrifuged at 22 000 x g for 20 minutes at 4 oC. The supernatant
was aspirated, and the lysis/centrifugation/aspiration cycle was
repeated. The resulting membranes were resealed by incubation in
KCI medium at 37 oC for 60 minutes and harvested by
centrifugation at 22 000 x g for 20 minutes at 4 o
Glucose Transport Protein. Glucose transport protein was
purified from human erythrocytes as described previously (Hebert
and Carruthers 1992). The carrier co-purifies with red cell lipid and
is incorporated into unsealed proteoliposomes upon removal of
by dialysis (Carruthers 1986).
Glucose Carrier Labeling with 8-Azidoly32PjATP. Labeling was
as described previously (Carruthers and Helgerson 1989). Briefly, a
methanolic solution of 8-azido(y- P)A TP is dried under nitrogen and
resuspended in 500 IlL Tris medium pH 8. 5 (90 /lCi , 10 /lM final
(azidoA TP)). Purified GLUTI proteoliposomes (500 /lg protein) are
sedimented by centrifugation at 14 000 x g for 20 minutes and
combined with the methanol-free 8-azido (y_32P)A TP solution. The
suspenSIOn is incubated on ice for 30 minutes by which time A 
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binding to GLUTI achieves equilbrium. Samples are placed in a
plastic weigh boat on Ice and irradiated for 90 seconds at 280 nm 
a Rayonet Photochemical Reactor. Following uv irradiation
(photolabeling), GLUTI is washed three times to remove unbound 8-
azido (y_32P)A TP by centrifugation (14 000 x g for 15 minutes) and
resuspended in 500 IlL Tris medium pH 8.5. Photolabeling of Cos-
'recombinant hGLUTI is identical to that described above except for
the following 1) samples eluted from Ni-NTA were combined
the methanol-free 8-azido (y_32P)A TP at pH 7.4 , and 2)
rradiation was carried out in separate wells of a plastic ELISA dish
on Ice. The presence of detergent precludes washing the sample to
remove unbound azidoA TP. The effects of pH on azidoA TP binding
to GLUTI were examined by varying the pH of the Tris medium over
the range 5.5 - 8.5 during photolabeling. MgCl was present at 5 
in all experiments. Photolabeling of GLUTI was carried out at
concentrations of 8-azido 
(y-
P)A TP that were lower than the Km for
A TP binding to the transporter. In this instance, the amount of
bound 8-azido(y-32P)ATP is gIven as:
Bmax .
bound -(aZldoATPJ
This method makes it possible to detect changes in both the Bmax and
the Kd for 8-azido(y- P)ATP binding to GLUTl.
Glycoprotein Detection. Azido(y-32P)ATP photolabeled GLUT 1
carbohydrate was detected using the Amersham ECL Glycoprotein
If!,
Detection Kit. Briefly, peptide oligosaccharides are oxidized using 10 :1'
':;
mM sodium metaperiodate then labeled using 0.55 mM biotin
, hydrazide. Subsequent detection of biotinylated glycoprotein
mploys standard western blotting techniques using streptavidin-
peroxidase (1 :5 000) and ECL chemiluminescence.
Proteolysis of Labeled Carrier. Azido(y-32P)ATP- and/or biotin-
labeled GLUTI was sedimented by centrifugation at
14,000 x g for 20 minutes and resuspended in sample buffer :t
chymotrypsin, endoproteinase Lys- or endoproteinase Glu-
(protein/enzyme 20: 1 by weight). Proteolysis was allowed to
proceed for 30 minutes at 37 o and was arrested by addition of
phenylmethylsulfonylfluoride (PMSF, 0.2 mM). The resulting GLUTI
fragments were separated by gradient gel electrophoresis (10-20%
polyacrylamide SDS gels) and transferred to nitrocellulose
membranes for autoradiography and western blotting.
Polyacrylamide Gel Electrophoresis. Proteins were resolved on
10% acrylamide gels as described previously (Laemmli 1970) 
where separation of proteolytic fragments was required, gradient gel
electrophoresis (10-20% polyacrylamide gradients) was employed.
Western Blotting. Proteolytic fragments containing GLUTI
carboxyl-terminal residues 480-492 GLUTI N- terminal residues
88- and/or a hemagglutinin tag (HA) were detected by western
blot analysis. Peptides separated by SDS PAGE were transferred
electrophoretic ally to nitrocellulose or immobilon membranes,
which were subsequently blocked for 1 hour in PBS containing 15%
CarnationTM nonfat dry milk. Following three five-minute washes in
PBS, membranes were incubated for 1 hour in pnmary antibody
(C-Ab and N-Ab) diluted 1:1000 or (HA-ab) 1:400 in PBS containing
2% nonfat dry milk. Following three wash cycles to remove primary
antibody, membranes were exposed for 45 minutes to secondary
antibody (protein- or goat anti-mouse Horseradish Peroxidase
conjugate) diluted 1 :3000 in PBS containing 2% nonfat dry milk.
Detection of antigen/antibody/protein- complexes was by
chemiluminescence using Amersham ECL reagents.
:!:!
Protein Sequencing. Azido(y-32P)ATP- Iabeled GLUTI (100 Jlg) I.J
was sedimented by centrifugation at 14,000 x g for 20 minutes then
resuspended in 0. 1 % SDS/Tris- HCI pH 7.4 :! Jlg endoproteinase
Lys-C. Digestion was carried out for 18-24 hours at 4 oC. GLUTI
fragments were separated using mM thioglycolate pre-equilibrated
gradient gels. Peptides were transferred electrophoretic ally to PVDF
membranes and following detection by autoradiography and
- Coomassie blue staining, bands of interest were excised from the
membrane, washed extensively in distilled water and subjected to
microsequence analysis by Dr. John Leczyk of the University of
Massachusetts Medical School Protein Chemistry facility.
Net 3- Methylglucose Uptake. Sugar-depleted cells or ghosts at
ice temperature were exposed to 5 volumes of ice cold KCI medium
containing (3H)- 0 -methylglucose and variable concentrations of
unlabeled 3- 0 -methylglucose. Uptake was measured over intervals
of 15 seconds to 1 minute , then 50 volumes (relative to cell volume)
of stopper solution were added to the cell/ghost suspension.
, Cells/ghosts were sedimented by centrifugation (14 000 x g for 
seconds), washed once in stopper, collected by centrifugation, and
, extracted in 500 JlL of 3% perchloric acid. The acid extract was
'" centrifuged , and duplicate samples of the clear supernatant were
counted. Zero-time uptake points were prepared by addition of
stopper to cells/ghosts prior to addition of medium containing
sugar and radiolabel. Radioactivity associated with cells/ghosts at
zero.,time was subtracted from the activity associated with
cells/ghosts following the uptake period. All uptakes were
normalized to equilibrium uptake where cells/ghosts were exposed
to sugar medium at 37 oC for 60 minutes prior to addition of
stopper. Uptake assays were performed using solutions and tubes
pre-equilibrated to 4 o
Effects of Glycolytic Intermediates on 3- Methylglucose
Uptake. Glycolytic intermediates were introduced into human
erythrocyte ghosts by addition to the ice-cold resealing medium
prior to membrane resealing. The membranes were warmed to
37 oC for 60 min then resealed ghosts were harvested by
centrifugation (22 000 x g for 20 minutes at 4 OC), and washed once
in 50 volumes KCI medium to remove extracellular glycolytic
intermediates. Ghosts were then processed for 3-0-methylglucose
uptake measurements as described above.
Effects of pH on A TP-modulation of 3- O-methylglucose
uptake. Membrane ghosts were resealed in KCI medium containing
5 mM MgCl , varying (ATP) and adjusted to a pH ranging from 5.5 to
0. All other solutions (uptake media and stopper) were also
adjusted to the same pH. Ghosts were then processed for
0-methylglucose uptake measurements as described above.
Reconstituted GLUTI-mediated EggPC (40transport.sugar
mg in hexane) and cholesterol (10 mg) (:: 80:20 molar ratio) were
dissolved in hexane. The organic phase was evaporated under a
stream of N and remaining trace quantities of hexane removed 
vacuo for 3 hr. The resulting lipid film was dissolved in Tris medium
containing 5% (by weight) sodium cholate and mixed with 100 /lg
; '
GLUTI solubilized in 50 mM sodium cholate. This mixture (4 mL)
was dialyzed overnight against 6L detergent-free Tris medium and
the resulting suspensIOn of small unilamellar proteoliposomes
distributed into 0.5 mL fractions in microcentrifuge tubes. Each tube
was frozen in a dry ice/isopropyl alcohol mixture, thawed at room
temperature then subjected to 2 additional rounds of
freezelthawing. The resulting large unilammelar proteoliposomes
(mean diameter = 2. Jlm by oil immersion phase contrast
microscoPY) sedimented readily at 14 000 x g and were used for
sugar transport determinations at 24 oC. 30MG uptake (0.05 mM)
was measured into 100 JlL proteoliposome suspension (2 Jlg GLUT!)
at 0, 10, 20 , 30 and 60 sec in Tris medium :t 10 JlM CCB (a transport
inhibitor; K(app) = 0. JlM). Equilibrium uptake was measured by
incubation for 2 hr at 24 oC. Uptake was arrested by addition of 1
mL ice cold Tris medium containing 10 JlM CCB. Proteoliposomes
were sedimented by centrifugation at 14 000 x g for 5 min at 4 o
the supernatant was aspirated and the liposomes were washed agam
m Tris medium containing CCB. Uptake, v, was computed 
v = (30MGJ (cpm
cpm
(cpm
", 
cpm
where t is time, cpmo, cpmt, and cpm", correspond to radioactivity
associated with proteoliposomes at time zero, time t and 
equili bri um.
Tissue Culture. Cos-7 cells were maintained in Dulbecco
Modified Eagle Medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 100 units/mL penicilin, and 100 ug/mL
streptomycin in a 37 C humidified 5% CO incubator.
Construction of Wild Type Mutant GLUTI-HA His A 1. 
Kbp fragment of GLUTI cDNA was previously subc10ned into the
BamHI cloning site of pGEM3Z (pGEM3Z-GT1) (Zottola, 1995). Site
directed mutagenesis via a Stratagene QuickChange Kit was used to
introduce a unique Mfel restriction site at residue 1685 in pGEM3Z-
:)!
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GTI. An HA-His epitope tag was inserted into the coding region of
GLUTI at this location. The presence and orientation of the HA His
tag in the GLUTI coding region was confirmed by sequencing. The
tagged GLUTI was then further subc10ned into the BamHI site of
the pcDNA3. 1 + mammalian expression vector. Scanning alanine
mutagenesis was undertaken through the three conserved A 
binding domains found in GLUTI. Mutants were again engineered
with the Stratagene QuickChange Kit, and their presence was
confirmed by sequencing.
Transient Expression of Wild- type and Mutant GLUT in Cos-
7 cells. Subconfluent Cos-7 cells were transfected with wild type
and mutant GLUTI HA 6His cDNA using the Fugene 6 transfection
reagent system. Following transfection , cells were maintained in
DMEM for 24 hours, at which time 0.72 mM G418 (Geneticin) was
added to the media and the cells were allowed to continue growing
for an additional 48 hours. For harvesting, 6 culture plates of cells
(150 mm) were washed twice with PBS + 5 mM EDT A, then scraped
into 20 mL lysis buffer mixed with 1 mM eukaryotic cell protease
inhibitor cocktail, and PMSF. Membranes were prepared according
to Loo & Clark, 1993 (Loo et aI., 1993). Briefly, cells were
homogenized for five minutes with a Fisher Dyna-Mix, then spun 
5000 x g for 10 minutes at 4 C. The supernatant was decanted and
centrifuged at 100,000 x g for 1 hour to pellet the crude membrane
fraction. Membranes were resuspended in 300 L of Buffer A with 1
mM protease inhibitor cocktail and frozen at - C until use.
Purification GLUTl. Purification 0 of Wildtype and Mutant
recombinant GLUTI HA His was described in Loo and Clark, 1995
(Loo and Clarke, 1995). Briefly, extracts were solubilized in 1.7 mL
solubilization buffer (Buffer A + 1 % N-dodecyl ~- maltoside) then
spun at 15,000 x g for 15 minutes to remove insoluble material.
The supernatant was allowed to react for 1 hour at 4 C with 2 mls of
Ni-NT A column media which was pre-equilibrated with 4 buffer
B (buffer A + 0. 1 % N-dodecyl ~- maltoside). The column was
washed twice with 8 mL buffer B , and twice with 8 mL buffer C.
Samples were eluted from the column with 1.5 mL elution buffer
and concentrated in centricon- l0 concentrators.
glucose Uptake Cos- Cells with Wild Type Mutant
GLUTI-HA 6His. Subconfluent Cos-7 cells in 12 well culture dishes
were transfected with wild-type and mutant GLUTI-HA His
described previously. glucose uptake was measured at 72 hours
, !
post transfection. Prior to uptake, cells were serum starved in DME
for 2 hours at 37 C. Next, cells were washed twice with KRP then
incubated at 37 oC for 15 minutes in KRP +/- 10 j.M CCB. Cells were
exposed to 400 j.L (3H)2-deoxyglucose diluted 1 :40 in KRP (10 j.Ci)
containing O. mM unlabeled 2-deoxyglucose. Uptake was measured
at various times , from 5 minutes to 30 minutes and stopped by
washing twice with 1 mL ice cold KRP. Duplicate samples were
counted following extraction with 450 III 0. 1 % Triton-XI00. Time
zero uptake points were prepared by adding ice cold KRP to each
well before the addition of medium containing sugar and radiolabel.
Radioactivity associated with cell extracts at time zero was
, I
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subtracted from the activity associated with cell extracts following
the' uptake period. All uptakes were normalized for protein. Uptake
assays were performed USIng solutions and dishes pre-equilibrated
to 37 o
8-Antibody Binding. Cos- cells were grown and transfected in 12
well culture dishes as previously described. 8-antibody binding was
measured 72 hours post transfection. a-antisera reacts exclusively
with exofacial epitopes of tetrameric GLUTl. Unless noted, all
solutions were pre-warmed to 37 C. Cells were incubated for 1 hour
at 37 C with sheep 8-antibody diluted 1: 1000 in DMEM +10% fetal
bovine serum. Following two washes in KRP pH 7.4 , cells were
incubated for 30 minutes with (125 I)-protein G diluted 1: 1200 in KRP
(protein G recognizes and interacts with antibodies raised in sheep).
After two additional washes in KRP, duplicate samples were counted
following extraction in 500 ilL of 1 % triton in KRP pH 7.4. Protein G
binding to Cos- cells in the absence of primary antibody was used
to quantitate background radioactivity and was subtracted from
each sample. All measurements were normalized to the quantity of
protein present in each well.
Cytochalasin B Binding. Membranes from Cos-7 cells transfected
with GLUTI HA His and mutant 338A were isolated as described
previously. Samples were resuspended in 700 ilL 6.25 11M (3H)-
cytochalasin B (CCB), 100 11M phloretin , and 10 11M cytochalasin D
in PBS at pH 7.4 and allowed to equilibrate on ice for 10 minutes.
This suspension was placed in a plastic weigh boat on ice and
! '
irradiated for 4 minutes at 280 nM in a Rayonet Photochemical
Reactor. Following UV irradiation membranes were washed with PBS
to remove unbound CCB and sedimented by centrifugation
(100 000 x g for 15 min). Proteins were resolved on 10% SDS PAGE
gels and stained for protein or transferred to nitrocellulose for C-
and HA-Ab western blotting. Gel slices (0.2 cm) were extracted from
stained gels and incubated overnight at 50 C in scintillation fluid
containing 300 ilL 30% HzO z before being counted. All samples were
corrected for protein concentration.
Calculation of + and ATP levels. In some GLUTI
photolabeling experiments" pH and (A TP) were varied systematically
at fixed EGTA (4 mM) and MgCl (5 mM) levels. Exogenous CaCl was
not added, thus total Ca levels were limited to Ca-contamination
J I
(approx. 15 tLM; (Helgerson et aI., 1989)). Computation of Mg
, I
Mgz.ATP, Mg ATP , ATP , Mg EGTA , MgzHEGTA and EGTA levels was
carried out using the WinMaxC program (Bers et aI. , 1994) and
equilbrium constants cited by Smith and Martell (Martell and
Smith, 1974) for H+, Ca , Mg + and K+ interaction with EGTA and
ATP adjusted for pH and temperature (4 OC). The apparent
dissociation constants (-log) calculated for EGT A and A TP at pH 5.
are: KEGTACa = 2.91, KEGTAMg = 2. , KATpca = 3.30, KATPMg
= -
31; at pH 6
are: KEGTACa = 3.32, KEGTAMg = 3. , KATpca = 4.30, KATPMg = 0. 19; at pH 7
are: GTACa = 3. , KEGTAMg = 3.89, KATpca = 6.29, KATPMg 1.22; at pH 8
are: GTACa = 4. , KEGTAMg = 4.03, KATpca = 8.27, KATPMg = 2.39 and at
pH 8.5 are: KEGTACa = 4.03, KEGTAMg = 4.04, KATpca = 9. , KATPMg = 3. 10.
Our calculations confirm that Mg + levels decline linearly over the
pH range 5.5 to 8.5 (from 2.4 to 0.5 mM) due to increasing chelation
by EGT A and variable association with A TP. MgzA TP plus HA TP
levels increase from 2. 85 mM at pH 5.5 to a peak of 3.5 mM at 
0 and thereafter decline to 3.2 mM at pH 8.5. Free ATP levels are
greatest at pH 5. (1.4 mM), are lowest at pH 7 (0.4 mM) and
(Ji
thereafter increase to 0.8 mM at pH 8. :HI
Computation of transport and labeling constants. In some
experiments, transport rates and GLUTI labeling by A TP were shown
to change in a nonlinear (saturable) manner with increasing (A TP)
(e.g. Fig. 3). In these instances, best fit curves were generated by
regression using the software package KaleidaGraph
08d (Synergy Software, Reading, P A) and assuming the following
relationships:
Fig 3A pH 8, uptake = kl k2(ATP) where kl = basal transport in
dATP (ATP)
the absence of A TP, k2 is the increment in transport produced by
saturating A TP levels and KdATP is the apparent Kd for A TP interaction
with the transport system.
Fig 3A pH 5. , uptake = kl k2(ATP) k3(ATP) where kl , k2
dATPI (ATP) KdATP2 (ATP)
and KdATPI correspond to those parameters for Fig 3A pH 8 but where
k3 and KdATPz describe an additional interaction with A TP that
reduces net uptake.
Fig 3B pH 5.5 and 8. , labeling = k4 k5(ATP) where k4 is labeling
iATP (ATP)
In the absence of unlabeled A TP, k5 is the decrease in labeling
produced by saturating A TP levels and KiATP is the concentration of
A TP that inhibits labeling half-maximally.
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Chapter m
Factors Influencing A TP Modulation
Sugar Transport
of Erythrocyte
The A TP-sensitivity of human erythrocyte sugar transport
suggests that regulation of glycolysis and sugar transport in
nucleated erythrocytes (Wood and Morgan, 1969; Whitfield and
Morgan, 1983; Diamond and Carruthers, 1993) and cardiac tissue
(Mansford, 1968; Haworth and Berkoff, 1986) is coordinated
through a common regulatory principle. The major site of glycolytic
regulation is phosphofructokinase (PFK) which catalyzes the
committed step in glycolysis. PFK is subject to allosteric inhibition
by A TP and by citrate and to stimulation by fructose-
bisphosphate and by AMP and ADP (Carpenter and Hand, 1986).
Pyruvate kinase, the enzyme controlling the outflow from glycolysis
is subject to allosteric inhibition by A TP and to stimulation by
fructose- bisphosphate (Waygood et aI. , 1976; Rosevear et aI.
1987 ).
Work in this laboratory has shown that A TP is an allosteric
inhibitor of human erythrocyte GLUTI (Carruthers and Helgerson,
1989; Helgerson et aI. , 1989). The net effect of ATP on 30MG uptake
II red blood cell ghosts at subsaturating sugar levels (50- 100 M) is
to stimulate transport. In contrast, transport at saturating sugar
levels ( 100 lM) is inhibited (Helgerson et aI., 1989).
The sugar transport experiments that defined this A TP effect
were measured in red blood cell ghosts (human red blood cells
which have been hypotonically lysed) or inside out red blood cell
vesicles (IOV' s) resealed with and without 4 mM ATP at pH 7.4
(Helgerson et aI. , 1989). Under these circumstances, normal
parameters such as pH and cellular redox state are artificially
controlled. This is not however the case under normal physiologic
conditions. For example, sugar transport in cardiac and skeletal
muscle as well as nucleated erythrocytes responds to external
stimuli such as muscle contraction, anoxia, and inhibition of
oxidative metabolism (Cheung et aI., 1977; Simons , 1983; Whitfield
and Morgan, 1983; Haworth and Berkoff, 1986; Hansen et aI., 1995;
Lee et aI., 1995). We were concerned that our experimental system
lacked the types of intercellular communication (i.e. local
environmental conditions) that might exist in intact tissues and
organs. This led us to ask 1) What metabolic factors affect A 
modulation of GLUT1? 2) Does the oligomeric structure of GLUTI
contribute to the A TP effect?
To answer these questions , glycolytic intermediates, oligomeric
structure, and changing pH were tested for their ability to alter
30MG uptake into red blood cell ghosts resealed with 4 mM A TP. In
addition, these factors were examined for their capacity to affect
azidoATP photolabeling of purified GLUTl. Our findings suggest
that intracellular AMP and acidification antagonize A TP regulation
of sugar transport, and that A TP interaction with GLUTI is sufficient
for transport modulation. Our findings also support the hypothesis
that A TP regulates only tetrameric GLUT1.
Results
Glycolytic Intermediates
Glycolysis and GLUTI-mediated transport appear to be regulated
coordinately in certain tissues (Cloherty et aI. , 1996). We wanted to
investigate whether GLUTI-mediated sugar transport might be
subject to regulatory feedback mechanisms similar to those found in
the glycolytic pathway.
Intracellular (but not extracellular; see (Helgerson et aI. , 1989)
Mg.A TP converts 30MG transport by resealed erythrocyte ghosts
from a high capacity, low affinity transport system (V max =1069 :t 84
/lM/min, Km(app) = 12. 3 :t 0.8 mM) to a low capacity, high affinity
system (V mn = 220 :t 19 /lM/min, Km(app) = 386 :t 24 /lM; n=4). The
net effect of A TP is to increase 30MG uptake at 0. 1 mM sugar by 2
to 5 fold (see also (Carruthers and Helgerson, 1989)). We measured
30MG uptake at 0. 1 mM sugar to determine how resealing
erythrocyte ghosts with or without glycolytic intermediates affects
basal and A TP-modulated sugar transport.
Table 1 shows that intracellular AMP (2 mM) inhibits A TP-
modulation of transport. Extracellular AMP has no measurable effect
on basal or A TP-modulated 30MG transport. This result is not
unexpected becaus previous work in this laboratory has shown that
AMP , though unable to mimic the action of A . on transport,
competes with A TP i for access to the transport system (Carruthers
and Helgerson, 1989). Resealing ghosts with 2 mM ADP stimulates
Table 1: Effects of glycolytic intermediates
erythrocyte 30MG uptake
30MG uptake in JLmol/L cell wa ter/min
lAddition 0 Mg.A TP 4 mM Mg.A TP
no addition 19:t2 49 :t 3
AMP (2 mM) 4:t 1 7:t 1
ADP ( 2 mM) 39 :t 3
NAD (2 mM) no 
NADH (2 mM) no 
Pyruvate (4 mM) no 
Citrate (2 mM) no 
Lactate (2 mM)
Fructose 1 6 bisphosphate (4 mM)
Fructose 2 6 bisphosphate (4 mM) no 
HP0 (4 mM)
Diphosphoglycerate (2 mM) no 
Phosphocreatine (1 mM) no 
Phosphoenolpyruvate (0. 1 mM) no no 
Fructose- phosphate (0. 1 mM) no no 
Glucose- phosphate (0. 1 mM)
Glyceraldehyde- phosphate (0. 1 mM)
Phosphoglycerate (0. 1 mM) no 
Adenosine (50 JiM) no no 
Erythrocyte ghosts were resealed in KCI medium containing 5 mM MgCI plus
the addition shown and adjusted to pH 7.4.
no indicates that there is no significant difference between the test
measurement and the measurement observed with no addition. The number of
measurements per condition was 3 or more. Results are shown as mean :t SEM.
basal transport. This result was unexpected because ADP, like AMP
competes' with A TP for binding to the transporter. We hypothesize
that residual adenylate kinase present in red cell ghosts converts
ADP to A TP causing transport stimulation (Carru thers and
Helgerson, 1989). The remaining glycolytic intermediates and A 
analogs (including adenosine) are without effect on basal or A TP-
modulated transport whether applied at the cytoplasmic or
extracellular (not shown) surface of the erythrocyte membrane.
The experiments describing effects of glycolytic intermediates on
basal and A TP-modulated 30MG uptake were performed at pH 7.4.
Under physiologic conditions in muscle and erythrocytes, increased
glycolysis elevates cellular lactate levels resulting in acidosis (Cairns
et aI., 1993). We therefore examined the ability of altered pH
modulate ATP-regulation of GLUT I-mediated sugar transport. Red
blood cell ghosts were resealed in KCI medium containing or lacking
4 mM Mg.ATP adjusted to pH 5. , 6. , 7.0 or 8.0. Both extra- and
intracellular media were adjusted to the same pH to avoid pH
changes due to transmembrane proton flow. Earlier studies have
demonstrated that the extracellular sugar uptake site is remarkably
insensitive to alterations in external pH (Sen and Widdas, 1962). KCI
medium was employed in both extra- and intracellular media to
avoid transmembrane KCI gradients and K+ transport- induced
volume changes.
Figure 2A shows that as pH decreases from 8.0 to 5. , A 
modulation of 100 p,M 30MG uptake is reduced. Subsequent
, :I
experiments (see Fig 3A) show even stronger inhibition of A TP- ;i!
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modulated transport. Basal transport rates are unaffected.
Calculation of free Mg, free A TP and Mg.A TP levels indicates that
this inhibition is unrelated to systematic (pH-dependent) alterations
in the ionization state of A TP (see Materials and Methods). The loss
of A TP-modulation of transport at lower pH could result from
altered binding kinetics (affinity or capacity of GLUTI for A TP) or
from the pH dependent binding of a regulatory molecule to the
ATP-GLUTI complex. To examine these possibilities
, purified GLUTI
was photolabeled at pH 5.
, 6. , 7. , and 8. 5 with 10p,M azidoATP.
Previous studies from this laboratory have demonstrated that
Figure 2. Effects of pH on A TP-modulation of sugar transport (A) and
GLUT1-labeling by azido-(y_ P)A TP (8). A Erythrocytes were Iyzed and
resealed in KCI medium containing (8) or lacking (0) 2 mM exogenous ATP.
The pH of the resealing and extracellular media is shown on the abscissa.
Ordinate: initial rates of 100 
,uM 30MG uptake (,mol/L cell water/ min). These
results summarize triplicate measurements. Lines drawn through the data points
were computed by the method of least squares. 8 Purified GLUT1 was incubated
in Tris- HCI medium containing 10,uM azido-(y- P)A TP at the pH indicated for 15
minutes at 4 . C. Each sample was uv irradiated for 1 min and 30,ug of labeled
protein resolved on 10% SOS PAGE minigels. Proteins were transferred to
; J
nitrocellulose and labeled bands containing azido(y- P)A TP were identified by
, '
autoradiog raphy 
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GLUTI and azidoA TP associate reversibly to form a binary complex
and that azidoA TP binding to GLUTI is inhibited competitively by
A TP, ADP, and AMP (Carruthers and Helgerson
, 1989). Proteins were
resolved on minigels and labeling was quantitated by
autoradiography. Figure 2B shows that contrary to our expectations
ATP incorporation into GLUTI is reduced as the pH increases from
to 8.
To better understand this response to pH, we measured the
A TP-dependence of 30MG uptake in resealed red cell ghosts at pH
5 and 8.0. Figure 3A shows that 100JLM 30MG uptake increases in
a saturable manner with ATP concentration at pH 8.0. At pH 5.
however, transport is maximally stimulated at 200 
JLM A TP, but 
inhibited at 2 mM A TP. Figure 3B summarizes three separate
experiments in which azido(y- P)ATP labeling of GLUTI was carried
out at pH 5.5 and 8.0 in the presence of increasing concentrations of
unlabeled A TP. A TP inhibition of GLUTI labeling by azidoA TP shows
simple competition kinetics at both pH 5.5 and 8.0 but maximum
labeling by 
azidoA TP and (app) for A TP inhibition of labeling are
reduced at pH 8.0. The A TP content of erythrocyte ghosts resealed
Figure 3. Effects of pHon the concentration-dependence of A TP-
modulation of sugar transport (A) and ATP- inhibition of GLUT1- labeling by
azido-rf P)A TP (B). A. Erythrocytes were lysed and resealed in KCI medium
containing 5 mM MgCI plus increasing concentrations of ATP at pH 8.0 (8) or at
pH 5.5 (0). Ordinate: initial rates of 100 
tlM 30MG uptake (,mol/L cell water/
min). Abscissa: A TP content of the resealing medium in 
tlM. The results
summarize three separate experiments each made in triplicate. Lines drawn
through the data points were computed by nonlinear regression (see Materials
and Methods). These analyses assume that ATP-modulation of transport at pH 8
is comprised of basal transport (k1 seen at 0 ATP) plus a simple
, ATP-dependent
Michaelis- Menten component where k2 is the increment in transport produced by
saturating A TP levels and K
dATP is the apparent Kd for A TP interaction with the
transport system. The computed constants are: 
k1 = 46 tlM/min k2 = 30 tlM/min;
dATP = 89 tlM ATP. ATP-modulation of transport at pH 5.5 is similar to that at pH
8 but is characterized by an additional interaction with A TP that reduces net
uptake where k3 is the decrement in transport produced by saturating A TP levels
and KdATP2 is the apparent K for A TP inhibition of transport. The computed
constants are: k1 = 48 tlM/min k2 = 259 tlM/min; KdATP1 = 189 tlM ATP k3 = 259
tlM/min; KdATP2 = 199 tlM ATP. B. ATP- inhibition of GLUT1-photolabeling by
azido-(y- P)ATP at pH 5.5 (0) and pH 8.0 (8). Purified GLUT1 was incubated
for 15 minutes at 4 oC in Tris-HCI medium containing 5 mM MgC/
. 15 tlM azido-
(y_
PJATP at pH 5.5 or pH 8.0 in the presence of increasing concentrations of
ATP. Each sample was uv irradiated for 1 min and 30 Jig of labeled protein
resolved on 10% SDS PAGE minigels. Peptides were transferred to
nitrocellulose and labeled bands containing (y_ PJA TP were identified by
autoradiography. Ordinate: relative (y_ PJATP incorporation into GLUT1 as
judged by densitometric analysis of resulting autoradiograms. Abscissa: (A TPJ
present during photolabeling (mM). These data summarize 2 separate
experiments. Lines drawn through the points were computed by nonlinear
regression (see Materials and Methods). This analysis assumes that 
k4 is the
extent of labeling in the absence of ATP and that ATP competitively inhibits
labeling (k5 is the decrease in labeling produced by saturating A TP levels and
iATP is the concentration of A TP that inhibits labeling half-maximally). The
computed constants are: pH 8. k4 = (1. 1 :t 0. 1) x 10 k5 = (1.0 :t 0. 1) x 10
iATP = 0.5:t 0.2 mM ATP; pH 5. 5, k4= (4.7:t 0.3) x 10 k5= (4. 1 :t 0.5) x 10
iATP = 1.3 :t 0.5 mM ATP.
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with 4 mM ATP at pH 5.5 or 8.0 is not significantly different (pH 5.
(ATP) = 3. 1 mM; pH 8. , (ATP) = 3. 1 mM; ATP content of ghosts
resealed in the absence of exogenous A TP: pH 5.5, (A TP) = 0.07 mM;
pH 8. , (A TP) = 0.069 mM).
Oligomeric Structure
Erythrocyte-resident GLUTI exists as a homotetramer but
dissociates to form a homodimer upon erythrocyte exposure to
extracellular reductant (Hebert and Carruthers, 1992; Zottola et aI.
1995). In the present study we ask: does A TP modulate both dimeric
and tetrameric GLUTI-mediated sugar transport? Table 2 shows that
erythrocyte ghost exposure to reductant (2 mM DTT) inhibits A TP-
modulation of 30MG uptake but is without effect on basal uptake
measured in the absence of A TP. Reduced capacity to modulate
GLUTI-mediated sugar transport in reductant-treated erythrocyte
ghosts could result from reduced ATP binding to GLUTI or from
altered interaction of A TP- liganded GLUTI with regulatory cellular
components. Figure 4 shows that incorporation of 8-azido(y-32P)A TP
into reduced GLUTI is significantly impaired.
E.:7YJ' 
:.','
Table Effect of reductant TP-modulation
of erythrocyte 30MG uptake
30MG uptake
Condition pmollL cell water/min
Control 41.2 :t 7.4
2 mM DTT 57. 3 :t 7.
2 mM A TP 97.7:t 11.6
2 mM A TP + 2 mM DTT 48. 1 :t 3.4
Hypotonically Iyzed erythrocytes were resealed :t 2 mM A TP then incubated :t 2
::1
mM OTT for 30 min at 37 .C. 30MG uptake at 100 JiM 30MG was measured at 4
C. The table summarizes results as mean :t SEM of 3 separate experiments
' , "" "
made in triplicate.
Figure 4. Azido-(y- P)A TP labeling of dimeric and tetrameric GLUT1.
Purified GLUT1 was incubated in Tris-HCI medium + 5 mM MgCI :! 4 mM OTT
for 30 minutes at 4 oC. Following labeling with azidoATP 30/lg samples of
protein were resolved on 10% SOS PAGE minigels. Peptides were transferred to
nitrocellulose and bands containing (y- P)A TP were identified by
autoradiography. The presence (+) or omission (-) of OTT treatment is indicated
above each lane.
, I
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Does ATP modulate GLUTl mediated sugar transport directly?
Reconstitution of purified erythrocyte GLUTI into liposomes
(EggPC and cholesterol in an 80:20 molar ratio) containing and
lacking 2 mM Mg. A TP provides an in-vitro system that consists
solely of GLUT1 , A TP, and the lipid bilayer. Inhibition of sugar
transport into GLUTI proteoliposomes following treatment with
cytochalasin B (10 
JlM CCB) insures that we are measunng protein
mediated solute movement across the lipid bilayer as opposed 
non-specific leakage. Cytochalasin B (CCB) inhibitable 3-
\, methylglucose uptake by reconstituted GLUTI proteoliposomes is
I), robustly stimulated by 2 mM Mg.A TP (Figure 5).
Discussion
We examined whether A TP regulation of transport in resealed ghosts
is subject to modulation by glycolytic intermediates known to
regulate glycolysis. Only AMP antagonizes the action of A TP on
30MG uptake. Citrate
, fructose- bisphosphate and fructose-
bisphosphate (key 
regulators of PFK or pyruvate kinase) are without
basal or A TP stimulated sugar uptake. Other intermediates
Figure 5. ATP stimulates 30MG uptake into reconstituted , purified GLUT1
proteoliposomes. GLUT1 (100 Jig) was reconstituted into eggPC:cholesterol
proteoliposomes and uptake of 50 JiM 30MG was measured at 20 .C in the
presence of 5 mM MgCI :t 2 mM ATP , and in the presence or absence of 20 JiM
cytochalasin B (CCB). Ordinate: 30MG uptake expressed as % of the equilibrium
30MG space of proteoliposomes accessed during 15 sec of uptake; Abscissa:
(ATPJ of medium during reconstitution and uptake determination (0 or 2 mM
ATP). Uptake in the presence of CCB is shown by the solid bars. This figure is
representative of three separate experiments.
Figure 5
OATP 2 mM ATP
were similarly inactive. Adenosine also failed to modulate GLUTI
mediated sugar transport. This suggests that A TP is not interacting
with the adenosine receptor, nor is the adenine ring responsible for
the effects of A TP on GLUT1. ADP, however, mimics the ability of
A TP to modulate transport. These effects of AMP and ADP on sugar
transport in erythrocyte ghosts are similar to those reported
previously (Carruthers and Helgerson
, 1989). External application of
ADP inhibits A TP modulation of sugar efflux from inside out
erythrocyte membranes vesicles and, like AMP, antagonizes the
action of A TP which reduces C-Ab binding to purified GLUT 1
(Carruthers and Helgerson
, 1989). This suggests that residual
,adenylate kinase present in erythrocyte ghosts converts ADP to A TP.
" This hypothesis is supported by A TP assays of ADP-Ioaded ghosts
o.'
, (Carruthers and Helgerson
, 1989). We propose, therefore, that A TP
j, regulation of sugar transport is subject to inhibition by AMP and
possibly by ADP. The implication is that the glucose transporter - 
epzyme of glycolysis - is characteristically sensitive to the energy
of the cell.
All experiments investigating the action of glycolytic
intermediates on A TP modulation of sugar transport were
performed at fixed pH (7.4). Under normal circumstances, increased
glycolytic flux gives rise to elevated lactic acid levels and reduced
pH (Elliott et aI. , 1992; Cairns et aI., 1993; Smith et aI. , 1993). 
therefore examined the effect of altered pH on basal and A 
regulated sugar transport. To our surprise, we observed that while
reduced pH inhibited A TP-modulation of sugar transport
azido (y- P)A TP-Iabeling of GLUTI was increased. Reduced pH serves
to increase both maximum photoincorporation of 
(y-
P)A TP and
(app) for A TP-inhibition of photolabeling. A TP stimulation of
transport at pH 8. increases in a saturable manner with nucleotide
concentration. However
, A TP stimulation of transport at pH 5.
Increases with nucleotide concentrations up to 200 11M and
thereafter falls with increasing A TP. A TP assays indicate that
intracellular A TP is not degraded to a significantly greater extent at
low pH. Computation of free Mg , A TP and Mg.A TP levels indicates
that these observations are not explained by systematic, pH-
dependent changes in these species. We conclude that intracellular
A TP exerts antagonistic actions on sugar transport at pH 5. 5. The
nature of the inhibitory action is presently unknown. Increased
GLUTI labeling by azidoA TP at reduced pH raIses the possibility
that a unIque, transport-antagonistic A TP binding site is revealed at
acidic pH. Future studies must address this possibility.
Isolated GLUTI is an A TP binding protein. Resealing erythrocyte
ghosts with Mg.A TP results in sugar uptake stimulation at
subsaturating (30MG) and produces uptake inhibition at saturating
(30MG) (Carruthers and Helgerson
, 1989). Addition of 2 
Mg.ATP to reconstituted GLUTI proteoliposomes results in
stimulation of 30MG uptake at sub saturating (50 
tLM) 30MG levels.
ATP modulations of purified GLUTI and erythrocyte resident GLUTI
mediated sugar transport are, therefore, fundamentally similar. 
conclude that ATP , GLUT1 , and the lipid bilayer, are sufficient for
A TP modulation of GLUTI function.
This conclusion contrasts with that of Wheeler who
demonstrated that A TP does not modulate the activity of
reconstituted human GLUTI protein (Wheeler 1989). However
Wheeler studies employed reduced (DTT- treated) GLUTI which we
have shown to exist as a GLUTI dimer (Hebert and Carruthers
1992). Our studies employ the physiologic
, non-reduced form of
GLUTI (a GLUTI tetramer
, see (Hebert and Carruthers
, 1992). 
therefore asked two questions. 1) Is reduced GLUT susceptible to
A TP-regulation? 2) Does reduced GLUTI bind A TP? Our studies have
shown that reductant treatment of erythrocytes converts resident
tetrameric GLUTI to dimeric GLUTI (Zottola et aI. , 1995) and our
present findings indicate that reductant also ablates A TP-
modulation of 30MG transport. Reductant (DTT) treatment of
purified GLUTI results in the loss of azidoA TP labeling. These
results provide a rational explanation for Wheeler s findings and
suggest strongly that dimeric GLUTI does not present binding sites
to nuc1eotides. They further reinforce the view that red cell-resident
GLUTI exists as the A TP sensitive, GLUTI tetramer (Zottola et aI.
1995 ).
Chapter IV
Peptide Mapping the GLUTl ATP Binding Domain
Isolated human erythrocyte glucose transporter (GLUT1)
functions as an A TP binding protein (Carruthers and Helgerson
1989). Work in this laboratory has shown that the GLUTI carboxyl
terminus becomes less accessible to peptide-directed antibodies
following A TP exposure. This A TP dependent conformational change
is antagonized by AMP and ADP that appear to function as
competitive inhibitors of A TP binding to GLUTl. In this study we set
out to determine the location of the GLUTI nucleotide binding
domain.
To answer this question we applied peptide mapping and
N-terminal sequencing techniques to GLUTI photolabeled with
azidoATP, a photoactivatable P labeled , ATP analog. Our findings
suggest that GLUTI residues 301-364 form an integral part of the
A TP binding domain.
Results
Peptide Mapping
Previous studies from this laboratory have demonstrated that
GLUTI and azidoA TP associate reversibly to form a binary complex
and that azidoA TP binding to GLUTI is inhibited competitively by
ATP, ADP and AMP (Carruthers and Helgerson
, 1989). UV irradiation
of the azidoA TP/GLUTI complex activates the A TP azido group
sulting in covalent attachment of bound nucleotide to GLUTI. In
the absence of irradiation
, no measurable 8-azido(y- P)ATP is
incorporated into the carrier protein (Carruthers and Helgerson
1989). Limited proteolysis studies suggest that the point 
photoattachment of azidoA TP to GLUTI falls witbin the carboxyl-
terminal half of the protein (residues 270-456; see (Carruthers and
Helgerson, 1989). We have now undertaken a detailed peptide
mapping analysis to more precisely define the site of covalent
ttachment of nucleotide to GLUTl.
' '
Peptide mapping studies of integral membrane proteins such
as GLUTI are complicated by the typically hydrophobic nature of
the resulting peptides and by the presence of N- linked
oligosaccharide. For example, human erythrocyte band 7 proteins
include the multi-spanning integral membrane glycoproteins
aquaporin (28 kDa) and RhD (Mr = 45 kDa) (Smith and Agre, 1991)
but are resolved as a 32 kDa protein band upon 10% SDS PAGE
(Zottola et aI. , 1995). Intact GLUTI (Mr = 55 kDa) is resolved as a 50
kDa band (Fig 6A). We therefore decided to use GLUTI internal
markers to assist in peptide identification. Peptides containing N-
linked oligosaccharide (asn ) were identified by blot analysis (using
streptavidin-conjugated HRP) of GLUTI fragments obtained from
glucose transporter biotinylated on carbohydrate residues prior to
proteolysis. Pep tides containing GLUTI residues 88-95 (N-residues)
and/or 480-492 (C-residues) were identified by use of rabbit
antisera (N-Ab and C-Ab respectively) raised against synthetic
peptides corresponding to these GLUTI domains. Each experiment
(see Figure 6A) thus involves biotinylation of carbohydrate exposed
by unsealed GLUTI proteoliposomes
, followed by GLUTI
photolabeling using azido(y-32P)A TP. The labeled proteoliposomes
Figure 6. Peptide mapping of photolabeled 
GLUT1. A. Purified GLUT1 (40 j.g
biotinylated on carbohydrate residues) was photolabeled using 
10j.M azido-
fy_ P)A TP then incubated in sample buffer containing 5 j.g chymotrypsin (30
minutes at 37 .C). Peptides were separated on a 10-20% SOS PAGE gradient
gel , transferred to nitrocellulose. Azidofy- P)A TP-containing peptides were
detected by autoradiography e p). C-Ab and N-Ab reactive peptides were
detected using immunoblot analysis. Biotinylated carbohydrate (Glyc) was
detected by streptavidin blot analysis. C-
, N- , 32p and Glyc analyses were
performed on a sihgle common lane of electrophoretically separated peptides.
Major peptides are assigned a label (a through h) and are indicated by the
leftmost solid bars. The mobility and M of molecular weight standards are
indicated by the solid bars to the right of the figure.
B. EndoLys-C digestion and sequencing of azido-fy- P)ATP-photolabeled
GLUT1. Labeled
, purified GLUT1 (100 j.g) was incubated in 0. 1 % SOS , 50 mM
Tris-HCI medium
, pH 7.4 containing 5 j.g endoproteinase Lys-C (EndoLysC) or 5
j.g endoproteinase Glu-C (EndoGlu-C; 18-24 hours at 4 OC). Peptides were
separated on a 10-20% SOS PAGE gradient gel
, which had been pre-
equilibrated with 1 mM thioglycolate and subsequently transferred to Immobilon-
PVOF for staining with Coomassie blue. Bands containing 
(y_
P)ATP were
, identified by autoradiography e p). C-Ab and N-Ab reactive peptides were
detected using chemiluminescence immunoblot analysis. Major peptides are
assigned a label (i through 0) and are indicated by the leftmost solid bars. The
mobility and M of molecular weight standards are indicated by the solid bars to
the right of the figure. An intensely labeled 19 kDa band (peptide n) was excised
from the membrane , washed 10 times with distiled water and subjected to
sequence analysis by the UMMC Microsequencing Facility. A single sequence
was obtained as AGVQQPVY A 
T corresponding to GLUT1 residues 301-310.
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were subjected to limited proteolysis, peptides are resolved by SDS-
PAGE, transferred to immobilon or nitrocellulose
, and biotinylated
and/or 32P- Iabelled peptides are detected by autoradiography. The
same membrane filters are then probed for the presence of peptides
containing N- and C-residues by chemiluminescent immunoblot
analysis.
Figure 6A indicates that not all N- or C-Ab-reactive peptides
contain 32p or biotinylated carbohydrate. Similarly, not all 32p-
containing peptides include N- or C-Ab-reactive sequence. Figure 6B
shows EndoLys-C and EndoGlu-C (V8) digests of 8-azido(y-32P)ATP
labeled GLUTI which were subsequently probed for 32p and C- and
N-residues. One of the 32P-Iabeled peptides (figure 6B
, peptide n)
was subjected to N-terminal sequence analysis (see below). Figure 7
summarizes additional experiments in which azidoA TP- Iabeled
intact GLUTI was subjected to digestion by chymotrypsin (Figure
7 A) or by V8 protease (Figure 7B). Major peptides of Figures 6 and 7
have an assigned label and are aligned in Figure 8 according to size
sequence content (identified by internal markers) and proteolytic
specificity. This analysis permits approximate localization of the
Figure 7. Peptide mapping of photolabeled GLUT1. A. Purified GLUT1 (40
Jig) was photolabeled using 10 JiM azido-(y- P)A TP then incubated in sample
buffer containing 5 Jig chymotrypsin (30 minutes at 37 .C). Peptides were
separated on a 10-20% SOS PAGE gradient gel
, transferred to nitrocellulose.
(y-
P)ATP-containing peptides were detected by autoradiography e p). N-
reactive peptides were detected using immunoblot analysis. Major peptides are
assigned a label (p through u) and are indicated by the leftmost solid bars. The
mobility and M of molecular weight standards are indicated by the solid bars to
the right of the figure. B. V8-protease digestion of azido-(y- P)A TP-
photo/abeled GLUT1. Labeled
, purified GLUT1 (100 
Jig) was incubated in 0. 1 %
SOS , 50 mM Tris-HCI medium , pH 7.4 containing 8 or 15 Jig endoproteinase Glu-
C (EndoGluC; , 18-24 hours at 4 .C). Peptides were separated on a 10-20% SOS
PAGE gradient gel and subsequently transferred to Immobilon-PVOF for staining
with Coomassie blue. Bands containing (y_ P)ATP were identified by
autoradiography e p). C-Ab reactive peptides were detected using
chemiluminescence immunob/ot analysis. Major peptides are assigned a label (v
through bb) and are indicated by the leftmost solid bars. The mobility and M
molecular weight standards are indicated by the solid bars to the right of the
figure.
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Figure 8. Summary of peptide mapping analysis of (y- P)ATP-labeled
GLUT1 (Figures 6 and 7). The horizontal axis represents GLUT1 residues 1 to
492. labeled and unlabeled peptides are indicated by filled and open bars
respectively. Data are from Figures 6 and 7 and are cross-referenced by peptide
labels (a - bb). Peptides containing C-Ab reactive sequence overlap with GLUT1
residues 480 - 492. Peptides containing N-Ab reactive sequence overlap with
GLUT1 residues 88 
- 95. Peptides containing biotinylated carbohydrate also
contain GLUT1 residue asn
. When two peptides are linked by a single vertical
bar, this indicates that localization is ambiguous and the range of possibilities is
shown for the linked peptides. The length of each peptide was computed by
assuming that electrophoretic mobility accurately represents peptide molecular
weight. The shaded vertical box spanning GLUT1 residues 291-364 represents
that region of GLUT1 that most likely contains covalently attached (y_
PJATP.
The striped bar represents a 19 kDa
, (y_
PJA TP-Iabeled , endoLysC fragment
(peptide n) of GLUT1 whose N-terminal residue (A301 ) was confirmed by
sequencing. Peptides e and y should (but do not) contain (y_
pJA TP and are
shaded differently for comparison. Presumed specificities of proteolysis are:
Endo-LysC , K; V8 protease , 0 , E; chymotrypsin , F
Figure 8
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site of covalent attachment of 
(y_
P)A TP to residues 291 through
364. Recognizing that the masses of hydrophobic and glycosylated
proteins obtained by SDS-PAGE analysis are approximate
, this regIOn
of nucleotide attachment should be viewed with some caution. Two
peptides have properties inconsistent with this conclusion. 
Peptide e
(Figure 6A) and peptide y (Figure 7B) cross react with C-
, are
characterized by Mrapp 19.9 and 22.4 kDa respectively but contain
no detectable p. Three observations suggest that these peptides are
dysfunctional GLUTI fragments present in GLUTI proteoliposomes
pnor to labeling and digestion. 1) These C-Ab-reactive peptides are
observed occasionally in GLUTI preparations that are untreated by
proteolytic enzymes (Hebert and Carruthers, 1992); Cloherty and
Carruthers, unpublished observations). 2) Peptide does not
correspond to any possible V8-specific GLUTI cleavage product. 3)
Peptide n overlaps with peptides e and y, contains 32p and 
identified definitively by N-terminal sequencing (see below).
N- Terminal Microsequencing
To further refine definition of the site of nucleotide attachment
azido (y- P)A TP labeled GLUTI was subjected to endoproteinase
Lys- digestion. Endoproteinase Lys- specifically hydrolyzes amide
ester, and peptide bonds at the carboxylic side of lysine (Jekel et aI.
1983). Assuming the conditions of proteolysis reveal each cleavage
site and also favor EndoLys-
specificity, this enzyme is expected to
produce a 16 kDa GLUTI fragment corresponding to residues 301 -
456. Purified, azido-A TP labeled GLUT 1 was exposed to endoLys-
for 18-24 hours at 4 oC and the resulting peptides were resolved on
10-20% gradient SDS-PAGE gels. Following transfer to Immobilon-
membranes, the blots were exposed to film for autoradiography and
stained with Coomassie blue. Bands of interest were excised from the
membrane, and subjected to N- terminal microsequence analysis.
Figure 6B indicates that a 19 kDa band (peptide n) is heavily labeled
by 
(y-
P)ATP but lacks recognition sites for both N- 
and C-Ab. N-
terminal sequence analysis of this peptide yielded 10 pmol of a
single sequence of AGVQQPVY A T corresponding to GLUTI residues
301- 310.
Discussion
The results of our peptide mappIng studies point to GLUTI residues
291-364 as the smallest GLUTI cassette that contains covalently
attached azido (y32PJ-A TP. This result is consistent with previous
indirect studies suggesting that GLUTI residues 270-380 may 
involved in nucleotide binding (Carruthers and Helgerson
, 1989).
The present study offers significant improvement over our earlier
analyses because we have employed internal markers to indicate the
approximate origin of proteolytic fragments previously assigned on
the basis of peptide mass and assumed proteolytic enzyme
specificity alone. These markers are: GLUTI residues 84-96 (N-
residues), GLUTI residues 480-492 (C-residues) and asparagIne-
linked carbohydrate (asn ). Even USIng these markers
, however
interpretation of GLUTI peptide mapping studies is complicated by
the frequently anomalous mobility of GLUTI fragments upon SDS
:PAGE. For example
, an azido(y- P)-ATP labeled endoLysC GLUTI
, fragment with intact carboxyl- terminus is resolved as a 23 kDa
Jragment. EndoLys- specifically hydrolyzes amide
, ester, and
peptide bonds at the carboxylic side of lysine. Assuming specificity
in proteolysis (an assumption supported by sequence analysis of a
smaller endoLysC GLUTI fragment), this peptide could derive from
cleavage at lysine 300 or lysine 256. The predicted masses of these
, peptides (21 kDa and 25.8 kDa respectively) differ significantly
from the observed mass on SDS PAGE.
The smaller azido(y- P)-ATP labeled endoLysC GLUTI
fragment (19. 1 kDa) was subjected to N-terminal sequence analysis.
This confirmed the origin of the azido(y P)-ATP labeled GLUTI
I : 
i: 
fragment as ala 01 with hydrolysis occurring at lys30o
. Assuming
specificity and precise molecular weight determination
, this result
places the site of azido(y P)-ATP incorporation within a GLUTI
cassette comprised of residues 301-477 (theoretical molecular
weight = 19223 D). Our peptide mapping studies suggest that
azido(y P)-A TP incorporation occurs between GLUTI residues 291
and 364. This permits further refinement of the azidoA TP-
incorporation domain to residues 301 -364. This GLUTI domain
contains primary sequence that shares 50% identity with a region of
adenylate kinase previously shown to form a hydrophobic strand of
parallel B-pleated sheet flanking the adenine-ribose and
triphosphate chain of MgA TP (Fry et aI. , 1986).
This sequence
adenyl ate kinase Izl GQPTLLL YVDAG
GLUT 33z 343 GRRTLHLIGLAG
IS also found in the adenine nucleotide binding proteins glycogen
phosphorylase (Newgard et aI. , 1988), RAD3 (Reynolds et aI.
, 1985),
the ATP/ADP translocase (PIano and Winkler
, 1991), the human
brown fat uncoupling protein (Casteilla et aI. , 1989; Cassard et aI.
1990), phosphofructokinase (Valdez et aI.
, 1989) and the (X- & 
subunits of Fj ATPase (Ohta and Kagawa, 1986). Assignment of this
GLUTI domain to the glucose transport nucleotide binding pocket
while strengthened by our peptide
, mappIng studies
, remaInS
inferential in the absence of a detailed GLUTI structure. It is
interesting to note that GLUTI also contains the consensus Walker
motif GXXXXGKS/T
, which is found in a number of A TP and GTP
binding proteins (Fry et aI. , 1986). In GLUTl
, this sequence
(residues 111-118) may be exposed to the exterior of the cell
(Hresko et aI., 1994) suggesting that it assumes no role in
intracellular nucleotide binding.
Chapter
Alanine mutagenesis of the GLUTl consensus
binding sequences
ATP
Peptide mappIng and n-terminal sequencIng studies in this
laboratory have suggested that residues 301-364 comprise part of
the GLUTI ATP binding domain. This region of GLUTI contains
pnmary sequence that is 50% identical with a region of adenylate
kinase previously shown to form a hydrophobic strand of a parallel
pleated sheet flanking the adenine ribose and triphosphate chain
of Mg.ATP (Fry et aI. , 1986). Two additional consensus ATP binding
sequences have been identified in GLUTI (Fry et aI. , 1986). In order
to delineate further the location of the A TP binding site on GLUTI
we have mutated all of the residues in these three proposed regions
to alanine. Our findings suggest that residues 332-335 contribute to
the efficiency of adenine nucleotide binding to GLUTl. In addition
the data also show that residues 338-340 are necessary for normal
transporter function.
Results
Purification of Human GLUTl HA His
GLUTI is a glycosylated membrane protein that contains a single
linked oligosaccharide at asn
. The presence of this carbohydrate
makes it difficult to synthesize GLUTI in a bacterial system. We felt
that either a yeast system or a transient mammalian system would
fulfill our needs. Our data suggest that we were fairly successful in
expressing hGLUTI in a strain of Saccharomyces Cerevisiae
(RE700A) in which seven (hxt 1-7) of 20 putative glucose
transporter genes are disrupted or deleted. Unmodified, this strain
of yeast is unable to survive on standard glucose media (Table 3
Figure 9B). Following transfection with human GLUT1 , selected
clones are able to grow on and transport glucose as a sole carbon
source (Figure 9A & 9B). In addition, separation of whole cell
extracts for western blotting reveals a 55 Kd protein that reacts with
GLUTI C-Ab (Figure 10). The data suggest that we have successfully,
heterologously, expressed human GLUTI in yeast. Unfortunately,
this mutant yeast grows too sl wly and produces insufficient GLUTI
for our purposes.
Table 3: Characteristics of S. Cerevisiae strain RE700A
transfected with GLUT1
Carbon
GlucoseYeast GrowthSource Uptake
Wild Type Glucose
Wild Type Galactose
Wild Type Maltose
RE700A Glucose
RE700A Galactose
RE700A Maltose
RE700A + GLUT1 Glucose
RE700A + GLUT1 Galactose
RE700A + GLUT1 Maltose
S. Cerevisiae2 RE700A is aURA 52 
mutant with 7 of its glucose transporters (HXT 1-
deleted or disrupted.
RE700A transfected with HA His epitope tagged human erythrocyte glucose
transporter (GLUT1).
Figure 9. GLUT1 HA His expression in Saccharomyces Cerevisiae. A.
H)0-glucose uptake measured in RE700A +/- tagged GLUT1. Yeast were
grown to an 600 = 0.6 for uptake. 1-2 mL of cells were pelleted and washed in
PBS prior to addition of uptake media. All solutions except stop were preheated
to 37 C. Uptake of 100 /lM O-glucose was terminated at 5, 30, and 60 seconds
by washing with ice cold PBS pH 7.4. Following lysis , duplicate samples of
supernatant were counted in a Beckman scintillation counter. B. RE700A +/-
tagged GLUT1 grown on YP-maltose or minimal media + glucose.
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Figure 10. C-terminal GLUT1 antibody western blot of RE700A 
+/-
GLUT1 HA His Cell extracts were prepared from RE700A +/- tagged GLUT1
grown to an OD600 of 0.6. Prior to extraction , the yeast were washed twice with
ice cold 50mM Tris-HCI pH 7. 5, 10 mM NaN . Cells were combined with 0.2 mM
glass beads and 100 JlI of protein sample buffer containing 1 mM PMSF. The
mixture was vortexed briefly and 50 JlI of each sample was resolved on 10% SDS
PAGE gels that were transferred to nitrocellulose for western blotting with GLUT1
terminal antibody.
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We therefore decided to develop a mammalian transient
eXpreSSIOn system for GLUTl. Cos- cells are a simian kidney cell
line that is capable of correctly processIng GLUTl. (Mueckler et aI.,
1985; Schurmann et aI. , 1997). We introduced a hemagglutinin
(HA), 6 histidine (His )' tag to facilitate the purification of the
expressed human GLUTI (GLUTI HA His ). To accomplish this, a
unique Mfel restriction site was introduced at residue 1685 in a 1.7
Kbp fragment of GLUTI cDNA previously subc10ned into the BamHl
site of pGEM3Z (pGEM3Z-GT1) (Zottola et aI. , 1995). Following the
insertion of an HA His epitope tag at this site, the GLUTI was
further subcloned into the BamHI site of a pcDNA3. 1+ mammalian
expression vector. The benefits of attaching this tag are twofold; 
the His region binds Nickel-NT A allowing affinity purification of
recombinant protein and, 2) HA can be detected with standard
western blotting techniques, allowing us to differentiate between
parental Cos-7 GLUTI and tagged human GLUTI (GLUTI HA His
To purify hGLUT1 , Cos-7 cells were transfected with
pcDNA3. 1 GLUT 1 via the Fugene 6 transfection reagent system.
Cells were harvested and homogenized 72 hours post transfection
and membranes were isolated by high-speed centrifugation in 
Beckman TI50.2 rotor at 100 000 x g (Loo and Clarke, 1994). Due to
the hydrophobic nature of hGLUT1 , it is necessary to solubilize the
membranes before they are applied to the Ni-NTA. A non- ionic
detergent, n-dodecyl-~ D maltoside, was used to prepare samples for
purification because ionic detergents may interfere with the ability
of the protein to bind to the column (Loo and Clarke, 1995). The
solubilized protein was allowed to bind to the nickel matrix for one
hour with gentle agitation. The Ni-NTA column was washed with
increasing concentrations of imidazole (10-25 mM), and samples
were eluted with a solution of 500 mM NaCI and 300 mM imidazole.
Fractions were resolved on 10% SDS-PAGE gels and transferred to
nitrocellulose membranes for immunoblotting.
Standard western blotting techniques were used to identify the
GLUTI present on these membranes. Gels stained with Pro-blue
suggest that GLUTI HA His containing eluate is approximately 50%
pure. Rabbit antisera raised against a synthetic peptide
corresponding to hGLUTI residues 480-492 (C-Ab) was used to
locate and identify intact GLUTI in various purification fractions.
Human GLUTI and Cos-7 GLUTI show significant homology, thus C-
terminal Ab binding is indicative of total GLUTI concentration. To
quantitate hGLUT1 , we used anti-HA antisera which binds selectively
to epitope tagged hGLUTI. Figures llA & B show both the resulting
terminal and HA western blots from a standard GLUTI HA His
purification protocol using Cos- cell membranes. A single large
band with an approximate molecular weight of 55 KDa is visible in
the final elution fraction (eluate (E) on both blots. The presence of
both an intact C- terminus and an HA tag suggests that we have
successfully affinity-purified His tagged hGLUTI protein.
Alanine Scanning Mutagenesis of ATP Consensus Binding Sequences
Fry et al (Fry et aI. , 1986) showed that GLUTI contains three
potential consensus A TP binding sequences (Figure 1). Current
GLUTI topology would place consensus site I (G- S/T
residues 111- 117), within transmembrane domain 3. Consensus site
II (K-X- V - amino acids 225-229) lies within the large cytoplasmic
loop between domains 6 & 7. Finally site III (G- L (Y, I) X-
Figure 11. Purification of GLUT1 HA His from Cos-7 cells. HA-Ab (A) and G-
Ab (8) immunoblot analysis of samples of GLUT1 HA His transfected cell
membranes obtained during GLUT1 affnity purification on Ni-NT A. Isolated Gos-
7 cell membranes were solubilized in n-dodecyl-~-O-maltoside (lane 2) and were
applied to aNi-NT A column. Following flowthrough of non bound GLUT1 (lane
3), columns were washed with 300 mM NaGI plus 10 mM imidazole (lane 4), 300
mM NaGI plus 30 mM imidazole (lane 5) and 500 mM NaGI plus 300 mM
imidazole (lane 6). Fractions were collected and proteins were separated on 10%
SOS-PAGE gels and transferred to nitrocellulose for immunoblot analysis. A. The
presence of GLUT1 in each of the samples was detected with G-Ab. Purified
human erythrocyte GLUT1 was placed in the far left lane as a control. GLUT1
runs as a diffuse band with an approximate molecular weight of 55 kOa. Lower
molecular weight bands are proteolytic fragments of GLUT1. B. GLUT1 HA His
was identified with a mouse anti-HA antibody. Fractions correspond to and are
aligned with those in panel A. The mobility of molecular weight standards are
indicated by the solid bars to the left of the panels A and 8.
Figure 11
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residues 332-343) occupIes both a portion of the cytoplasmic
loop between helices 8 & 9 and transmembrane domain 9. Peptide
mapping studies from this laboratory (Levine et aI. , 1998) suggest
that the point of covalent A TP attachment to GLUT 1 is between
Arg301 - Met364. This proposed region of binding overlaps with
sequence III. Once a procedure for producing and purifying GLUT 
was in place , site-directed mutagenesis could be undertaken. To test
the involvement of the three domains in GLUTI A TP binding, we
changed the residues in each of the three proposed sites to alanine
(Table 4) and determined whether transporter function or azidoA TP
binding was altered.
D- glucose Uptake into Cos- Cells
To assess whether wild type and mutant hGLUTI are functional
we measured 2-deoxy-glucose (2DOG) uptake into Cos- cells
transfected with each of our pcDNA3. 1+ GLUTI constructs. 2DOG is
used in this instance because it undergoes phosphorylation and
remams trapped in the intracellular space. Cells expressing epitope
tagged hGLUTI show a two-fold increase in cytochalasin B (CCB)
Table 4 - GLUT1 Alanine Mutants
Mutant Name Original Sequence Mutation
111A 111 GFSK114 111 AAAA114
225A 225KSVLK229 225 AAAAA 229
332A 332G R R334 332 AAA 334
335A 335TLH337 335 AAA 337
338A 338LIG340 338 AAA 340
341A 341 LAG 343 341 AAN
inhibitable sugar transport above basal levels (i.e. transport
measured in untransfected cos-7 cells, or in cells transfected with
pcDNA3. 1 + lacking GLUT1 HA His cDNA) (Figure 12). Transfection
with alanine mutants: lIlA, 225A, 332A, 335A, and 341A also
results in a 2-fold stimulation of transport (Figure 12). We
hypothesized that this increase was a result of greater GLUT1
presence at the plasma membrane. We tested this possibility by
measuring 8-antibody binding to Cos- cells +/- hGLUTl. Because
this antibody recognizes an exofacial epitope of tetrameric hGLUT1
its binding is an approximate measurement of transporter
expression at the membrane. Cos- cells transfected with tagged
GLUT 1 exhibit a 2-fold increase in 8-antibody binding above Cos-
cell levels (Table 5). This confirms our original assumption that
transport stimulation is a direct result of enhanced GLUTI presence
at the plasma membrane.
In contrast, mutant 338A shows only basal transport activity
and is considered non- functional. This mutant, as we wil discuss
later, retains its ability to bind azidoA TP. This result implies that
Figure 12. 2-deoxyglucose uptake in Cos-7 cells transfected with GLUT1
HA Hisij. Comparison of 200G (0. 1 mM) uptake at 37 oC by Cos7 cells , Cos-
cells transfected with vector (pcONA3. 1) lacking GLUT1 sequence and by Cos7
cells expressing GLUT1 HA His and GLUT1 HA His alanine mutants. Ordinate:
CCB- inhibitable 200G accumulation (mol per min per Jig total cell protein).
Abscissa: cells in which transport was measured. Results are shown as mean
:tSEM of triplicate measurements.
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Table 5: o-Antibody binding to Cos-7 Cells transfected with
GLUT1
Cos-7 Cells
Cos-7 Cells + GLUT1
HA His
Cos-7 Cells + 338A
Antibody Binding
cpm 
125 protein G
per /lg total protein
SEM
2658 704
5595 427
2199
1 N= experiments carried out in duplicate
alanine substitution at residues 338-340 does not grossly affect
transporter quaternary structure (i.e. GLUTI is folded correctly with
respect to A TP binding). To test this hypothesis, CCB (cytochalasin
B) photoincorporation into GLUTI was measured in membranes
isolated from unaltered Cos- 7 cells, as well as cells that had been
transfected with GLUT1 HA His and 338A. Membranes containing
tagged wild type GLUTI bound 2-fold more CCB than Cos-7 cells
alone (Figure 13A). In contrast CCB binding in 338A membranes
was equivalent to that found in basal Cos-7 membranes (Figure
13B). The absence of CCB binding and the retention of azidoATP
binding imply that some aspect of the mutant transporter structure
disrupted.
It is also possible that GLUTI trafficking to the plasma
membrane is disrupted. To better understand these results, 8-
antibody binding studies as previously described were applied to
Cos- cells transfected with mutant 338A. Interestingly, 338A
exhibited the same level of antibody binding as untransfected Cos-
cells, and 2-fold less binding than cells containing wild type hGLUTI
(Table 5).
Figure 13. Photolabeling of parental GLUT1 and transfected wild type and
mutant human GLUT1 in Cos-7 cells by the sugar export site ligand (3HJ-
CCB. Cos-7 cell membranes were photolabeled in the presence and absence of
1 00 M phloretin. Membranes were washed to remove unincorporated (3H)-CCB
and membrane proteins were separated by SOS-PAGE. Following Coomassie
staining, each gel lane was sliced into 2 mm sections , dissolved and counted for
associated (3H)-CCB. Ordinate: phloretin inhibitable CCBincorporation (cpm).
Abscissa: relative mobility (gel slice number). A. CCB incorporation in Cos-
cells , and cells transfected with GLUT1 HA His . B. CCB incorporation in Cos-
cells transfected with GLUT1 HA His and alanine mutant 338A.
Figure 13
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AzidoATP Labeling of Wild Type Mutant hGLUTl
To test whether alanine substitution affects A TP binding to the
transporter, we measured azidoA TP incorporation in GLUTI HA His
(mutant & wild type) purified from Cos- cells. Wild type and
mutant hGLUTI were affinity-purified from Cos- cells as described
previously. Proteins eluted from the Ni-NTA column were
concentrated using an Amicon centricon- 10 spun at 5000 x g for 
hour in a Beckman JA- 17 rotor. Samples labeled with azidoA TP were
equilibrated for 30 minutes in 10- 15 IJM azidoATP then UV
irradiated for 90 seconds at 280 nM in a Rayonet Photochemical
reactor. Fractions were simultaneously resolved on three 10% SDS-
P AGE gels and transferred to nitrocellulose. Two of the membranes
were used for C-Ab and HA-Ab western blotting. The third blot,
which contained photolabeled hGLUT1 , was exposed 
autoradiographic film for 5-24 hours. Densitometry was used to
quantitate epitope tagged GLUTI and azidoA TP incorporation. Total
protein concentration for each of the constructs was measured with
a Pierce BCA kit, and a uniform quantity of each mutant protein was
applied to all three gels.
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Western blots and azidoA TP autoradiographs for each alanine
mutant are shown in Figure 14. Lane 3 (4 mM ATP) shows purified
epitope tagged GLUTI (from lane 4) labeled with azidoA TP in the
presence of 4 mM cold A TP. The absence of radiolabel incorporation
suggests that A TP and 8-azidoA TP bind to the same site on GLUTI
HA His . This same effect has been seen previously, using purified
human erythrocyte GLUTI (Carruthers and Helgerson, 1989; Levine
et aI. , 1998).
AzidoA TP binding in each alanine mutant was compared to
incorporation in wild type GLUTI HA His . The ratio of photolabel
(azidoA TP) to HA antibody was used as a measure of A TP
attachment to tagged transporter. Mutants lilA, 335A, 338A, and
341A bound quantities of azidoA TP that were equivalent to that
found in GLUTI HA His (Figure 15). In contrast, mutants 225A and
332A exhibited a 1. to 2. fold Increase in photolabel
incorporation (Figure 15). Three possible explanations for this
increased A TP incorporation are: 1) The small sidechain of alanine
reduces steric interactions that normally limit A TP access to the
transporter-binding site. 2) By exchanging polar residues with
103
Figure 14. Azido( p)ATP labeling of GLUT1 HA His and its corresponding
alanine mutants. A. Transporter was purified by Ni-NT A affinity chromatography
of membranes isolated from Cos-7 cells transfected with wild-type or mutant
GLUT1 HA His (see Figure 11). Purified GLUT1 was photolabeled using 10 pM
azido( P)ATP , resolved on three separate 10% SOS PAGE gels (25pg total
protein per lane per gel) and transferred to nitrocellulose for western blotting and
autoradiography. For each group of mutants an internal control of GLUT1 HA His
was also processed. Control protein is visible at the far left of each group of blots.
GLUT1 constructs were identified by C-Ab and HA-Ab immunoblot analysis.
Incorporated affnity label (azidoATP) was detected by autoradiography. Antibody
and ATP binding were quantitated by densitometry using NIH Image. The ratio of
azidoATP labeling to HA-Ab reactivity is shown below the blots. Lane 3 (4 mM
ATP) shows that Ni-NTA purified GLUT1 HA His photolabeling byazidoATP
(lane 4) is inhibited in the presence of 4 mM unlabeled ATP.
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Figure 15. Corrected AzidoATP labeling of GLUT1 HA His (wild type and
mutant). AzidoA TP labeling of tagged GLUT1 (wild type & mutant) is presented
as a ratio of A TP/ HA antibody binding. This distinguishes azidoA TP labeling of
recombinant human GLUT1 HA His from parental GLUT1.
Figure 15
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uncharged alanines, sequence hydrophobicity and subsequently
A TP binding are increased. 3) Charge alterations loosen the
structure of the binding pocket.
GLUTI HA His and 332A were also subjected to competition
analysis of A TP inhibition of azidoA TP photoincorporation. Affinity-
purified GLUT1 HA His and 332A were photolabeled with azidoA 
in the presence of increasing concentrations of unlabeled A TP.
Membranes were then subjected to SDS-PAGE, transferred to
nitrocellulose and quantitated for azidoA TP incorporation by
autoradiography and densitometry. As with azidoA TP photolabeling
of isolated purified human erythrocyte glucose transport protein
(Levine et aI. , 1998), photoincorporation of azidoA TP into affinity
purified GLUT1 HA His and 332A is inhibited half-maximally by 50-
150 JLM ATP (Figure 16). With GLUTI 332A, however,
photoincorporation of azidoA TP in the absence of A TP is some 10-
fold greater. This suggests that increased photoincorporation of
azidoA TP into mutant 332A results from increased efficiency of
mutant GLUTI labeling. HA-Ab immunoblot efficiency is unchanged
by azidoA TP photolabeling of GLUTl.
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Figure 16. ATP- inhibition of azidoATP photolabeling of affinity purified
GLUT1 HA His6 (0) and GLUT1332 (8). Purified , epitope-taggedGLUT1 was
photolabeled as in Figure 14 in the presence of increasing unlabeled (A TP).
Proteins were resolved by SDS-PAGE and label incorporation and epitope-
tagged GLUT1 were quantitated by densitometry of P-autoradiograms and Ha-
Ab immunoblots. Ordinate: the ratio (32P) incorporation: HA-Ab reactivity.
Abscissa: (ATP) present during photolabeling in JiM. Curves drawn through the
points were computed by nonlinear regression assuming that inhibition of
photolabeling shows simple saturation kinetics and is characterized by the
. P(ATP)
expression: labelincorporation = N - where N IS label
Kj(app) + (ATP)
incorporation in the absence of unlabeled ATP , P is the amount by which
saturating unlabeled A TP inhibits label incorporation and Kj(app) is that
concentration of unlabeled ATP which reduces labeling by P/2. The following
constants were obtained: GLUT1 HA His , N= 0.66 :! 0.01; P=0.41 :! 0. , Kj(app) =
54:! 17 JiM ATP; GLUT1 332 3A' N= 11. 2:! 0.7; P=11.3:! 1. 0, Kj(app) = 127:! 49 JiM
ATP.
Figure 16
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Parental Cos-7 GLUTI may be able to form heterotetramers with
GLUTI HA His . This could make it difficult to visualize the effects of
GLUTI mutagenesis on azidoA TP binding. For example, if 3 units of
parental GLUTI and 1 unit of tagged GLUT1 form a tetramer
alterations in labeling caused by alanine substitution in the single
subunit may be partially camouflaged. To examIne this possibility,
Cos-7 membranes +/- GLUTI HA His were stripped of peripheral
membrane proteins with an alkaline wash and labeled with
azidoA TP. Samples were resolved on 10% SDS-PAGE gels and
photolabel incorporation was measured. The same quantity of total
protein was found to bind 3-fold more azidoA TP from cells
transfected with GLUTI HA His than non-transfected cells (Figure
17). This suggests that parental Cos-7 GLUT1 , present in
preparations of nickel purified , epitope tagged hGLUT, should not
obscure the affects of alanine mutagenesis on azidoA TP binding.
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Figure 17. AzidoATP labeling of Cos-7 cell membranes stripped of
peripheral proteins. Isolated Cos-7 cell membranes from control cells or from
cells transfected with GLUT1 HA His were labeled with azidoA TP following
removal of peripheral proteins by alkaline wash. Samples were resolved on 10%
SDS PAGE gels and transferred to nitrocellulose. Protein contents were
determined using a Pierce SCA assay kit , and 35 g of total protein were loaded
in each lane. Label incorporation was detected by exposure of membranes to
autoradiographic film. AzidoATP binding was quantitated by densitometry using
NIH Image. Membranes from GLUT1 HA His transfected cells contain 3 fold
more azidoA TP label than membranes isolated from nontransfected cells.
:',
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Discussion
In this study we ask the question; Does alanine substitution at
the three proposed GLUT 1 consensus A TP binding sequences affect
sugar transport and azidoATP binding? As a result of our alanine
mutagenesis studies, we have expressed HA His tagged human
erythrocyte GLUTI in: Cos- cells. Intact Cos- cells expressing
GLUTI HA His exhibit normal sugar transport under basal
conditions. In addition , purification of the protein on a Ni-NT A
column provides a transporter that is normal with respect to A 
binding capacity.
We compared 2-deoxyglucose (2DOG) uptake in Cos- cells +/-
GLUTI HA His as a measure of epitope tagged GLUT 1 function
and/or cell surface expression. Transfection with GLUT 1 HA His
(wild type) and 5 of the six mutant constructs (111A, 225A, 332A
335A, and 341A) resulted in a two-fold stimulation of transport
above basal Cos- cell levels, and levels observed in cells transfected
with empty pcDNA3. 1 + vector. This increase in transport is most
probably the result of a 2-fold increase in cell surface transporter
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expreSSIOn. We tested this hypothesis by measurIng 8-antibody
binding to Cos-7 cells +/- GLUTI HA His . We observe that cells
expressmg GLUTI HA His present 2-fold more 8-antibody reactive
cell surface sites than untransfected Cos- cells. This result confirms
our initial hypothesis that transport stimulation in transfected cells
IS a direct result of greater transporter presence at the plasma
membrane.
In comparison, cells transfected with mutant 338A display
unchanged sugar transport rates. This construct, as we wil discuss
later, retains its ability to bind azidoA TP. This suggests that the
oligomeric structure of 338A is not affected by alanine substitution
at least with respect to A TP binding. This hypothesis was examined
by measuring (3H)-CCB binding to membranes isolated from Cos-
cells transfected with GLUTI HA His , and 338A. Tagged GLUTI
(wild type) binds 2-fold more CCB than 338A or Cos- cells. These
results suggest that some structural component of mutant 338A is
altered (although ATP is still able to bind). Most probably, it is the
regIOn of GLUTI that contains the closely related sugar efflux and
CCB binding sites (Sultzman and Carruthers 1999). Alterations in
i:- -
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the sugar-binding site might also explain the inability of 338A to
transport sugar.
Two other possibilities could explain the inability of 338A to
transport sugar. 1) Transporter trafficking to the plasma membrane
may be disrupted. 2) The affinity of 338A for sugar may be altered.
8-antibody binding studies were used to test whether 338A is
expressed at the plasma membrane. The data show that 8-antibody
binding in 338A transfected cells is the same as that observed in
untransfected Cos- cells. The lack of 8-antibody binding may 
due to the absence of 338A at the plasma membrane or, because 8-
antibody recognizes an exofacial epitope of tetrameric GLUT1
alanine substitution at 338-340 may disrupt GLUT1 oligomeric
structure. The use of a configuration insensitive GLUTI exofacial-
in this protocol may resolve this question.
Schurmann et al. observed that transport was lost in GLUT4
when conserved residues 333R/334R were converted to alanine
(Schurmann et aI. , 1997). These results contrast with our work that
shows normal transport activity in GLUTI mutant 332A. This
difference may be explained by their reconstitution of GLUT4 into
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vesicles to measure uptake. In companson, our experiments were
carried out in intact Cos- cells. Substitution of alanine at this site
results in a loss of charged residues. These amino acids might be
responsible for retaining transporter topography in the membrane.
In their absence, 333R/334R may lose topographical stability when
exposed to detergent during reconstitution.
We assumed that the strategy of alanine mutagenesis would
decrease, or ablate, azidoA TP binding to GLUTI. However this was
not the case; in fact two constructs (225A, and 332A) incorporate
1.5 to 10-fold more azidoATP than GLUTI HA His or the other
mutants. This increase in labeling was somewhat unexpected and
does not reflect altered affinity for A TP but rather, altered efficiency
of photolabeling.
The overall increase in azidoA TP labeling observed in 225A
and 332A might be a result of alanine substitution reducing the
steric hindrance that normally limits ATP access to the GLUTI ATP
binding pocket. Alternatively, the presence of additional alanines
makes consensus sequences II, and III more hydrophobic. Increasing
their similarity to the proposed consensus sequences may allow
-' 
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more azidoA TP to bind to the transporter. Finally, alterations in
transporter charge may result in the loss of stabilizing cation-
interactions (Gallivan and Dougherty, 1999), which could affect A 
binding. Assuming that increased A TP incorporation does not reflect
a secondary action in which mutations introduced at a distal site
nonspecifically alter ligand binding within the nucleotide-binding
pocket, this effect might be consistent with a direct perturbation of
the nucleotide-binding domain.
,,:1
large range appears to exist in the maXImum amount of
azidoA TP that can be incorporated into mutant 332A. Densitometry
of photolabeled 332A shows a 1.5- 3 fold increase in azidoA 
labeling (Figure15), as opposed to competition analysis (ATP
inhibition of azidoA TP incorporation) which suggests 10-fold higher
azidoA TP labeling (Figure 16). This discrepancy may be a result of
autoradiogram overexposure in the photolabeling experiments
which could alter the 32p detection sensitivity of the technique.
The effects of mutating residues 332-335 on GLUT1 A 
binding are consistent with N-terminal sequence analysis of peptides
obtained upon proteolysis of azido A TP-photolabeled GLUTI. These
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studies indicate that the GLUTI A TP binding domain lies between
GLUTI residues 301 and 364 (Levine et aI. , 1998). Since GLUTI
sequences 307 to 327 and 338 to 358 are strongly hydrophobic and
thus putative membrane spanning a-helices (Mueckler et aI., 1985),
they are unlikely to be accessible to cytosolic A TP. In contrast
GLUTI residues 332-335 and the remainder of the Walker B domain
fall in the intervening (cytosolic) sequence between these membrane
spanning regions and may be well-positioned for interaction with
A TP and modulation of the sugar translocation pathway.
AzidoA TP and A TP binding to purified human erythrocyte
GLUTI are mutually exclusive , suggesting that they bind at the same
site on the protein (Carruthers and Helgerson, 1989). To determine
that this is also the case in epitope tagged GLUT1 , we labeled
purified GLUT1 HA His with azidoATP in the presence of 4 mM ATP.
The absence of 32 P incorporation confirms the stereospecificity of
azidoA TP binding to tagged GLUTl.
It is probable that parental GLUTI and tagged GLUTI
oligomerize to form tetrameric GLUT1. However, Cos- cell
membranes transfected with GLUTI HA His bind 3-fold more
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azidoA TP than a comparable amount of protein from untransfected
membranes. This suggests that the presence of parental GLUT1 in
samples of affinity purified epitope tagged GLUTI does not obscure
changes in azidoA TP binding that are a direct result of alanine
mutagenesis.
'--
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Chapter
Significance & Future Directions
This thesis examInes several hypotheses. First, we tested the
capacity of various physiologic factors to influence A TP modulation
of GLUTI mediated sugar transport. Specifically, we looked at the
effects of glycolytic intermediates, intracellular pH, and transporter
oligomeric structure. Next we asked, is ATP interaction with GLUTI
sufficient for sugar transport modulation? Third, we investigated the
location of the nucleotide binding domain on the human
erythrocyte glucose transporter. Finally, having narrowed the
possible location of the ATP binding site on GLUT1 , we analyzed
whether alanine mutagenesis altered sugar transport and A 
binding.
We have concluded that only AMP , and possibly ADP , inhibit
ATP regulation of GLUTl. Previous work in this laboratory has
shown that AMP , and ADP , though unable to mimic the effects of
A TP compete with A TP for access to the transport system
(Carruthers and Helgerson, 1989). This suggests that the adenosine
ri;
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moiety is responsible for binding, while phosphate chain length
dictates the ability of a compound to modulate GLUT 1 activity. The
present study shows that adenosine alone is insufficient for
modulation of human GLUTI function.
An increase in glycolysis can lead to an elevation in cellular
lactate levels and subsequent acidosis (Cairns et aI. , 1993). This
encouraged us to examine how alterations in intracellular pH affect
A TP regulation of GLUTI. From these studies, we observed that as
pH decreases from 8. 0 to A TP modulation of GLUT1 is inhibited.
We propose that this loss of A TP regulation results from altered
binding kinetics (affinity or capacity of GLUTI for A TP) or from the
pH dependent binding of a regulatory molecule to the A TP-GLUTI
complex.
The data indicate that pH affects A TP-GLUTI binding kinetics.
Surprisingly, we found that low pH increases (32P)A TP binding while
the (app) for A TP-inhibition of photolabeling is unchanged. Merino
et al. (Merino et aI., 1997) has shown that pH also modulates the
structure of the nucleotide-binding domain on A TPase.
Specifically, low pH was found to increase access to the A TP binding
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site. A similar mechanism could explain the increase in azidoA 
binding that we have observed in GLUTI as pH is lowered from 8.
to 5.
To better understand how low pH inhibits A TP regulation of
GLUT1 , we examined the ATP dependence of 30MG uptake into red
cell ghosts at pH 5.5 and 8.0. Uptake was found to increase in a
saturable manner at pH 8.0. In contrast, 30MG uptake at pH 5.5 was
maximally stimulated at 200 JlM A TP and inhibited at 2 mM A TP.
Degradation of A TP at low pH was ruled out as a cause of this
unexpected result.
We have concluded that A TP acts in, an inhibitory fashion on
sugar transport at low pH. In view of the increase seen In photolabel
incorporation at pH 5.5, transport inhibition was unexpected. This
result alluded to the possibility that low pH unmasks a unIque
transport-antagonistic ATP binding site on GLUTl. The exposure of
such a site would account for both the increase in A TP binding and
the inhibition of transport seen under acidic conditions. Transport
inhibition could also be the result of GLUTI interacting with a 
dependent inhibitory protein.
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We have shown that GLUT1 reconstituted into
proteoliposomes containing 2 mM A TP exhibits transport
stimulation at sub saturating 30MG. We have therefore concluded
that GLUT1 , the lipid bilayer, and ATP are the only components
required for A TP modulation of GLUTI function. This same system
could be used to rule out or confirm the presence of a pH inducible
regulatory protein. If transport inhibition is seen in this system at
pH 5.5, we can say with some certainty that a regulatory protein 
not the agent arresting transport at low pH.
Wheeler (1989) was unable to recreate the A TP effect in a
reconstituted system. His ' experimental design used the reduced 
dimeric form of the transporter. In contrast, our studies employ the
physiologic or tetrameric form of the transporter (Hebert and
Carruthers 1992). This laboratory has observed that exposure to
reductant (dithiothreitol-DTT) inhibits A TP modulation of 30MG
uptake. Specifically, conversion of tetrameric GLUTI to its dimeric
form results in loss of azidoA TP labeling. This explains the disparity
between the two data sets. We conclude that tetrameric GLUTI is
regulated by A TP.
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Although GLUT1 functions as an A TP binding protein, the
location of its nucleotide binding domain is currently unknown. Past
experiments have suggested that covalent incorporation of azidoA TP
to GLUTI falls within the range of C-terminal residues (270-456)
(Carruthers and Helgerson, 1989). The peptide mapping studies
carried out in this thesis identify residues 291-364 as a likely
component of the GLUTI azidoA TP-attachment site. The strong
hydrophobicity of GLUTI presents a problem for estimating the
molecular weight of GLUTI fragments by gel mobility. To balance
this uncertainty, we used internal markers (C- terminus , N- terminus
carbohydrate, and azidoA TP), and proteolytic enzyme specificity to
identify peptide fragments more definitively. More recent work in
our laboratory has shown that A TP increases GLUTI resistance to
proteolytic digestion (Cloherty and Carruthers, unpublished
observations). This may offer an explanation for the difficulty 
encountered obtaining complete proteolytic digests of azidoA 
labeled GLUTl.
Digestion of purified erythrocyte GLUTI with endoproteinase
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Lys- produces a peptide fragment whose first ten amInO acids were
identified by N'-terminal sequencIng as GLUT1 residues 301-310.
This sequence and the peptide mapping data allow us to further
refine the proposed azidoA TP-attachment site on GLUTI to a
cassette that contains residues 301-364. Importantly, this range of
residues overlaps with a proposed Walker B motif in GLUT1.
We have shown that A TP competitively inhibits azidoA TP binding
to purified GLUT1 (Carruthers and Helgerson, 1989). This implies
that azidoA TP and A TP bind to the same site on the transporter. The
proposed pocket structure of a nucleotide-binding domain (Fry et
aI., 1986) presents certain problems when using 8-azidoA TP for
peptide mappIng. Specifically the azido moiety that sits on carbon 8
of adenine may crosslink to a peptide adjacent to the actual binding
site. For this reason GLUTI peptide mapping experiments using
2-azidoA TP should also be performed in an effort to identify other
GLUTI segments contributing to the nucleotide binding pocket. If
8-azidoA TP 2-azidoA TP crosslink to adjacent peptides, digestion
of 2-azido labeled GLUTI might produce a significantly different
pattern of labeled peptides.
;::!.
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To further delineate the location of the A TP binding site, we
constructed alanine mutants for each of the three proposed
consensus sequences on GLUT 1 and measured azidoA TP labeling of
and sugar transport by, each mutant GLUTl. This required the
development of a GLUTI expression system. Unfortunately, the
yeast strain we created (RE700A + GLUTI HA His ) grew too slowly
and produced insufficient GLUTI for our purposes. Currently, more
clones are being screened to select one with a high rate of growth
and human GLUT expression.
This problem led us to develop a transient mammalian
expressIOn system for human GLUTI usmg Cos- cells. Purification
of HA His tagged GLUTI on a nickel column produced large
quantities of a protein which run as a diffuse band with 
approximate molecular weight of 55 kDa. Western blotting with
GLUTI C- , and HA- , identified this as epitope tagged human
erythrocyte glucose transporter. In addition, in-vivo transporter was
found to be normal with respect to sugar transport, and the isolated
transporter was normal with respect to azidoA TP binding.
B:.
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Transfection of Cos-7 cells with epitope tagged wild type GLUT1
and five of the SIX alanine mutants, resulted in a 2-fold increase in
DOG uptake above basal Cos-7 cell levels. 8-Antibody binding studies
have shown that cells transfected with GLUT1 HA His present a 2-fold
excess of GLUTI at the plasma membrane relative to untransfected Cos-
cells. This suggests that the transport stimulation we observed in Cos-
cells expressing epitope tagged GLUT1 , is the result of increased
transporter expression at the cell membrane. As a cautionary note, one
cannot rule out the possibility that these newly expressed proteins
stimulate transport, in part, by having a higher rate of catalytic turnover
than parental GLUT1. However, increased transport parallels
quantitatively the change in cell surface binding of a polyclonal
antiserum (8-Ab) directed against exofacial epitopes of GLUTl. Km(app) for
GLUT I-mediated 2DODG transport in human red cells is 15 mM (Stein
1986). The measurements reported in the present study were made at 0.
mM 2DOG. Transport is, therefore, given by
uptake 
max f2DODG)
m(app)
::-\%';
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where V max (the cellular 2DOG transport capacity) = kcat(GLUTILell surface
where kcat is the intrinsic catalytic turnover of GLUTI. Since bo th
transport and (GLUTl)ceii surface are doubled by Cos- cell transfection with
GLUT1 HA His this suggests that the k / Km(app) ratio for expressed GLUTI
HA His in Cos- cells is not significantly different from that of Cos-7 cell
endogenous GLUT1.
338A was the only mutant whose catalytic activity may have
been affected by alanine substitution. 30MG uptake by this
construct was not significantly different from uptake in
untransfected Cos- cells. This was suprising because these residues
(338-340) are located in a proposed transmembrane domain of
GLUTI and are, like alanine , uncharged. The fact that this mutant
retains its ability to bind azidoA TP suggests that its oligomeric
structure is unchanged with respect to the nucleotide binding site.
In contrast, phloretin inhibitable photoincorporation of CCB into a
55 kDa protein in membranes expressing mutant 338A is not
significantly different from that observed with membranes isolated
from non- transfected cells. The absence of CCB binding implies that
a portion of mutant 338A structure is disrupted. Because this
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mutant retains azidoA TP binding, the CCB labeling data suggest that
the disrupted region in question encompasses the proposed GLUT 
CCB binding and sugar efflux sites , which are closely related
(Sultzman and Carruthers 1999).
The lack of 2-deoxyglucose uptake by the 338 mutant could
result from disabled sugar transport, a result consistent with the
loss of CCB binding. Alternatively, the transporter may not be
expressed correctly at the plasma membrane. Incorrectly trafficked
GLUT 1 that is structurally intact, could still bind azidoA TP in these
studies because total solubilized Cos- cell membranes are applied
to the nickel column for epitope tagged GLUT 1 purification.
To test this possibilty, cell surface 8:-antibody binding was
measured in Cos- cells transfected with mutant 338A. The results
show that mutant 338A expressing cells bind the same amount of
antibody as Cos- cells alone, but 2-fold fewer IgGs than cells
expressing wild type epitope tagged GLUTl. The lack of o-an ti body
binding may be due to the absence of 338A at the plasma
membrane or alternatively, alanine substitution at 338-340 may
convert tetrameric GLUT1 to dimeric GLUT1. In this instance 8-
130
antibody, which recognizes an exofacial epitope of tetrameric
GLUT1, would be unable to recogmze the protein. If this is the case
the affinity of mutant 338A for 2DOG or its ability to translocate
2DOG may be altered. Immunohistochemistry using a configuration
insensitive exofacial GLUTI antibody may resolve this question.
We therefore conclude that the lack of sugar transport in mutant
338A is a result of one or more of the following: 1) dysfunctional
GLUTI trafficking to the plasma membrane, 2) abnormal oligomeric
structure in a small region of the transporter, and/or 3) an altered
quaternary structure.
Originally; we hypothesized that converSIOn of an essential
amIno acid to alanine would knock out, or reduce, azidoA TP binding
to the transporter. Contrary to this expectation , 225A and 332A
were found to bind 1.5 to 2. fold more azidoA TP than GLUTI HA
His or the other alanine mutants. It is possible that the charge
alterations in these mutants loosen the structure of the transporter
resulting in increased access of the N group of azidoA TP to the A 
binding pocket. Another explanation is based on the small side
chain found on alanine. In both 225A and 332A, alanine replaces
~~~~
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polar amino acids that contain large side chains. Removal of these
barriers could reduce steric hindrances controlling access to the
nucleotide binding pocket. Another possibility is related to the
hydrophobic nature of Sequence III. This stretch of amino acids in
GLUTI was found to contain 50% homology to a Walker B box which
is highly hydrophobic (Fry et aI. , 1986). Substitution of uncharged
alanines for polar residues in GLUTI (i.e. 332-334 GRR), Increases
the hydrophobic nature of this regIOn. By making GLUTI sequence
III more like a true Walker B motif, we may have enhanced azidoA TP
binding to the transporter. In the absence of a change in the k for
A TP inhibition of azidoA TP labeling in GLUT 1 HA His and mutant
332A, it is doubtful that the increased label incorporation that we
have observed in mutants 225A, and 332A is due to altered
transporter affinity for ATP. The reactive N of azidoATP may simply
be in closer proximity to (i.e. have increased probability of reacting
with) side chains in the pocket.
Another obstacle that concerned us was the potential for
parental GLUTI oligomerization with tagged GLUTI (both mutant
and wild type). GLUT1 HA His containing Cos- cell membranes
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bound 3-fold more azidoA TP than membranes from cells lacking
tagged GLUT1. We propose that the presence of parental GLUTI in
these preparations should not obscure the affects of alanine
mutagenesis.
We were particularly interested to observe that azidoA TP
incorporation into purified human erythrocyte GLUTI at low pH
increases in a manner similar to that found with epitope tagged
GLUTI mutant 332A purified from Cos- cells. Ki(app) for ATP-
inhibition of azidoA TP GLUTI HA His labeling is not reduced
indicating that transporter affinity for A TP is not increased by
mutation of these residues. AzidoA TP labeling of red cell GLUTI is
increased 5 to 10-fold by lowering pH from 8.5 to 5.5 yet Ki(app) for
ATP-inhibition of labeling is unchanged (Levine et aI., 1998).
Histidine is the best candidate amino acid for side-chain protonation
as pH is lowered from 8.5 to 5.5. GLUT1 contains 5 histidine
residues of which four (H 160, 239, 337 and 484) are located within
cytoplasmic domains. One of these, H337, is found in the putative
GLUT 1 Walker B domain although direct involvement in pH-
dependent modulation of azidoA TP binding efficiency wil require
tg'
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confirmation by substitution mutagenesis. Why would His
protonation mImIC (alanineh substitution for 332GRR? One clue may
be obtained from the hydrophobic GLUT1 sequence preceding the
putative Walker B mqtif. This sequence contains a phenylalanine
that could pair with Arg333 or Arg334 by cation-n interactions
(Gallivan and Dougherty, 1999). These interactions, which attain
approaching -4 kcal/mol, can significantly stabilize protein
structure (Gallivan and Dougherty, 1999). If the neighboring His
were protonated at reduced pH, it might disrupt Phe-Arg cation-n
interactions by charge repulsion of Arg . Removal of Arg333 or Arg334
by mutagenesis or protonation of His ? could relax local GLUTI
structure permitting closer interaction of the uv activated azidoA 
nitrene with GLUTI side chains or backbone. This structural
relaxation could increase the efficiency of label photoincorporation
without changing the affinity of the transporter for nucleotide.
While speculative, this hypothesis warrants experimental scrutiny.
Fluorescence resonance energy transfer (FRET) is another
technique that can be used to further delineate the location of the
GLUT 1 nucleotide binding domain. We have collaborated with a
134
visiting orgamc synthetic chemist (Dr. Boris Yagen, Hebrew
University, Jerusalem) to synthesize a fluorescent A TP derivative
anthraniloyl-A TP (AN-A TP). AN-A TP has an absorbance maximum at
343 nm and an emISSIOn maXImum at approximately 450 nm.
AN- ATP binding to 2 tLM GLUTI is half maximal at 7 tLM AN-ATP
with k and koff constants of 0. 3 per tLM per min and 2. 1 per min
respectively (Cloherty, Yagen and Carruthers, unpublished). AN-ATP
also mimics the abilty of ATP to modulate GLUT I-mediated
transport in red cells.
Using the intrinsic tryptophan fluorescence of GLUT1 (excitation
at 298 nm, emission max 332 nm) to excite AN-A TP bound 
GLUT1 , we have observed fluorescence resonance energy transfer
(FRET) between GLUT1 tryptophan residues and bound AN-A TP.
AN-A TP fluorescence requires GLUTI tryptophan fluorescence
because in the absence of this energy source, AN-A TP shows
extremely low fluorescence. Using this technique, we can map the
location of the GLUTI nucleotide-binding domain as it relates to
tryptophan residues within the transporter. By utilizing Ni-NT A
column purification of epitope tagged human GLUT 1 , we can
1l-
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synthesize and isolate GLUT1 mutants in which tryptophan has been
converted to glycine or leucine, thereby identifying tryptophan
residues in close proximity to bound AN-A TP
;;?
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